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Abstract
Genetic robustness, or fragility, is defined as the ability, or lack thereof, of a biological entity to maintain function in the face
of mutations. Viruses that replicate via RNA intermediates exhibit high mutation rates, and robustness should be particularly
advantageous to them. The capsid (CA) domain of the HIV-1 Gag protein is under strong pressure to conserve functional
roles in viral assembly, maturation, uncoating, and nuclear import. However, CA is also under strong immunological
pressure to diversify. Therefore, it would be particularly advantageous for CA to evolve genetic robustness. To measure the
genetic robustness of HIV-1 CA, we generated a library of single amino acid substitution mutants, encompassing almost half
the residues in CA. Strikingly, we found HIV-1 CA to be the most genetically fragile protein that has been analyzed using
such an approach, with 70% of mutations yielding replication-defective viruses. Although CA participates in several steps in
HIV-1 replication, analysis of conditionally (temperature sensitive) and constitutively non-viable mutants revealed that the
biological basis for its genetic fragility was primarily the need to coordinate the accurate and efficient assembly of mature
virions. All mutations that exist in naturally occurring HIV-1 subtype B populations at a frequency .3%, and were also
present in the mutant library, had fitness levels that were .40% of WT. However, a substantial fraction of mutations with
high fitness did not occur in natural populations, suggesting another form of selection pressure limiting variation in vivo.
Additionally, known protective CTL epitopes occurred preferentially in domains of the HIV-1 CA that were even more
genetically fragile than HIV-1 CA as a whole. The extreme genetic fragility of HIV-1 CA may be one reason why cell-mediated
immune responses to Gag correlate with better prognosis in HIV-1 infection, and suggests that CA is a good target for
therapy and vaccination strategies.
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Introduction
Genetic robustness is defined as the ability of a biological entity
(e.g. a protein or organism) to maintain function in the face of
mutations [1,2]. More robust proteins or organisms tolerate higher
mutation rates while less robust (more ‘brittle’ or ‘fragile’) proteins
or organisms are intolerant of mutation and are more likely to lose
function or be driven to extinction by high mutation rates. Viruses
that replicate via RNA intermediates using non-proofreading
polymerases exhibit high mutation rates, suggesting that robust-
ness should be particularly advantageous to them [3]. Indeed,
under some conditions, viral populations that exhibit high
robustness at the expense of high fitness might be favored over
those that have high fitness but low robustness [4–6]. In other
words, robustness/fragility might be a more potent selective force
than fitness under some circumstances.
While the robustness or fragility of RNA viruses has been
investigated in several studies [4–9], most reports characterize
robustness by treating an entire viral genome as a single biological
entity. However, viruses encode a variety of proteins that execute a
range of functions to enable replication, and the genetic robustness
of individual proteins is expected to vary within a given virus. Even
within a single protein, individual domains may exhibit variation
in robustness/fragility. Proteins that perform complex or multiple
functions that are highly dependent on accurate structure (e.g.
enzymes), should tend to be more genetically fragile, i.e less
tolerant of mutation, and exhibit greater sequence conservation
than those that do not (e.g. proteins that simply provide peptide
binding sites to recruit other proteins).
However, in their natural setting, i.e. a susceptible host,
animal viruses often replicate in a hostile and changing
environment, shaped partly by adaptive immune responses.
Such immune responses can take the form of antibodies that
target proteins displayed on the surface of the virion, or
cytotoxic lymphocytes that can target epitopes in nearly any
viral protein. Hence, at least some viral proteins, even those that
should exhibit genetic fragility, are placed under strong
evolutionary pressure to diversify in sequence, because they
are targeted by adaptive immune responses. Under such
conditions, otherwise fragile proteins might be expected to
evolve higher robustness. However, the potential trade-off
between robustness and fitness might impinge on each property,
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and it is unclear whether simple fitness, or the acquisition of
robustness, would constitute the dominant selective force on a
given viral protein in a natural setting.
One such protein in which the competing needs to preserve
function yet diversify sequence might conflict in a particularly
acute manner, is human immunodeficiency virus type I (HIV-1)
capsid protein (CA). As a critically important viral protein, it is
placed under strong selective pressure to maintain its structure and
perform several functions. Conversely, as a highly expressed,
immunologically visible protein, CA also experiences a competing
pressure to diversify its sequence. CA exists both as a domain
within the Gag precursor polyprotein during particle assembly,
and as an autonomous protein in the mature virion. Both Gag and
CA are multifunctional proteins [10–13]. Specifically, during
virion morphogenesis, Gag molecules assemble at the plasma
membrane and drive the formation of roughly spherical immature
virions, containing radially arrayed Gag molecules, that bud
through the plasma membrane [14,15]. However, during and after
viral budding, the viral protease (PR) is activated and catalyses the
cleavage of Gag at five positions, causing profound morphological
transformations [13]. In particular, the liberated CA protein forms
a conical capsid that encapsulates the nucleocapsid-genomic RNA
complex [16,17].
Like all retroviral CA proteins, a single HIV-1 CA molecule is
composed of two domains: the N-terminal domain (NTD)
comprised of 146 amino acids, and C-terminal domain (CTD)
comprised of 85 amino acids. The NTD structure consists of an N-
terminal b hairpin and 7 succeeding a helices, while the CTD has
4 a helices, and a C-terminal unstructured region of 11 residues
[18–20]. The NTD and CTD are joined by an interdomain linker
region (residues 146–150). Other noteworthy features of CA
include the major homology region (MHR residues 153–172) of
the CTD, which is a highly conserved 20 amino-acid region found
in all retroviruses [21] and the likely binding site of ABCE1 [22],
and a loop (NTD residues 85–93) which binds the cellular protein
cylophilin A [23]. The mature HIV-1 capsid consists of,1100 CA
monomers assembled into a hexameric lattice with 12 pentameric
declinations [16,24], that are distributed in such a way that the
viral capsid takes the form of a fullerene cone. Within the lattice,
the NTD is primarily responsible for intra-hexamer contacts, while
the CTDs form dimers that link adjacent hexamers [25,26].
However, interactions between the NTD and CTD also contribute
to proper capsid formation [26–29].
In addition to its major structural role, CA is a key determinant
of several other biological properties of HIV-1. For example, HIV-
1 capsid is the key determinant that enables HIV-1 to infect non-
dividing cells [30,31]. Related work has identified genetic or
physical interactions with host proteins karyopherin b transportin-
3 (TNPO3), nucleoporin 153 (NUP 153), nucleoporin 358
(NUP358)/RanBP2 and cleavage and polyadenylation factor 6
(CPSF6) [32–36]. Moreover, interactions between HIV-1 capsid
and cyclophilin A influence nuclear import and subsequent
integration site selectivity, as well as replication efficiency, in a
cell type dependent manner [37–40].
CA is a key target of intrinsic, innate and adaptive immune
defenses. Specifically, CA is targeted by TRIM5a [41], and may
be detected by undefined sensors in dendritic cells [42]. HIV-1 CA
also adapts under immune selection in vivo [43–46]. In particular,
host CD8+ cytotoxic T lymphocyte (CTL) responses to HIV-1
infection are critical determinants of viral control [47,48], and
there is an association between Gag- and capsid-specific CD8+ T-
cell responses and in vivo viral burden[49]. The emergence of viral
‘escape’ mutations in CA can result in higher viremia [50,51].
However, escape mutations often incur a significant fitness cost,
which may be subsequently compensated for by secondary
mutations in CA, or drive reversion when immune pressure is
lifted [45,51,52].
Previous studies in which CA was mutated have aimed to
elucidate the importance of particular domains, regions, and
residues in CA functions. Those targeted mutagenesis studies
largely relied upon insertion [53], deletion [54], or alanine or
proline scanning [55,56]. Here, we took a different approach to
investigate the genetic robustness of HIV-1 CA. Specifically, we
describe the generation of a large randomly mutagenized library of
CA sequences to simulate the natural process of random mutation
that occurs during HIV-1 replication. Strikingly, we find that CA
is extremely intolerant of nonsynonymous substitutions, with
,70% of random single nucleotide substitutions leading to a .50-
fold reduction in replicative fitness. We also determined the
biological basis for this extreme genetic fragility and found that
requirements imposed by the need to accurately and efficiently
assemble a mature virion are largely responsible. Indeed, a subset
of mutants were temperature sensitive (ts), and the conditional
non-viability of these mutants was always manifested during the
formation of virions. Interestingly, fewer than half of the CA
mutations that might be expected to occur in vivo, based on their
high replicative fitness, were actually observed in natural
populations. This finding suggests that CA sequence is constrained
in vivo, not only by the need to maintain replicative fitness, but also
by other unknown selective pressures. The mutational fragility of
HIV-1 CA demonstrated herein is consistent with the relatively
high overall degree of amino acid sequence conservation observed
in natural populations, and potentially explains the apparently
limited capacity of HIV-1 to evade immune responses directed
against epitopes in CA.
Results
Experimental design and analysis
To construct a library of random mutants of HIV-1 CA, a low
fidelity PCR approach was used, as illustrated in Figure 1A. In this
scheme, CA encoding sequences were amplified by error-prone
PCR and cloned using a TOPO TA cloning Kit to generate a
library with an estimated complexity of 16104 clones. Plasmid
DNA extracted from the pooled library was then digested, and CA
Author Summary
The HIV-1 capsid protein (CA) is absolutely essential for
viral replication and there is, therefore, intense evolution-
ary pressure for HIV-1 CA to conserve its functions.
However, HIV-1 CA is also a key target of the host immune
response, which should provide evolutionary pressure to
diversify CA sequence. Genetic robustness, or fragility, is
defined as the ability, or lack thereof, of a biological entity
to preserve function in the face of sequence changes.
Thus, it should be advantageous to HIV-1 CA to evolve
genetic robustness. Here, we present the results of
extensive, random mutagenesis of single amino acids in
CA that reveal an extreme genetic fragility. Although CA
participates in several steps in HIV-1 replication, the
biological basis for its genetic fragility was primarily the
need to participate in the efficient and proper assembly of
mature virion particles. The extreme genetic fragility of
HIV-1 CA may be one reason why immune responses to it
correlate with better prognosis in HIV-1 infection, and
suggests that CA is a good target for therapy and
vaccination strategies.
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sequences inserted into a replication competent proviral clone
encoding EGFP in place of Nef (pNHGcapNM acces-
sion:JQ686832, referred to as WT or parental virus hereafter)
using unique NotI and MluI restriction sites, introduced by silent
mutagenesis into sequences flanking those encoding CA
(Figure 1A). Thereafter, nearly 1000 individual colonies were
picked and proviral plasmid DNA was extracted from individual
mini-cultures. The mutagenized CA sequence was then sequenced
for each clone, and after failed sequencing reactions or
chromatograms indicating the presence of more than one template
were removed, the resulting library consisted of 680 arrayed
proviral plasmids. The distribution of all nucleotide changes
(Figure 1B), missense mutations (Figure 1C), and nonsense and
other mutations (Figure 1D) within the library was then
determined. The PCR-mutagenesis conditions were optimized in
pilot experiments so as to reduce the representation of non-
mutated and heavily mutated CA sequences in the library.
Consequently, the most frequent mutation in the library was a
single nucleotide or amino acid substitution (Figure 1B, C, D).
Viability of a large panel of HIV-1 CA mutants
To measure the genetic robustness of CA, we analyzed the
ability of the 680 mutants to replicate. Specifically, replicative
fitness was measured by means of a spreading infection assay, in
which MT-4 cells were challenged with a low volume of virus-
containing supernatant derived from transfected 293T cells
(equivalent to an MOI of ,0.01 for the WT virus). Multiple
rounds of the virus replication cycle were allowed to occur before
halting the experiment when the WT virus had infected .50% of
cells (72 to 80 hours later). Replicative fitness for each CA mutant
was expressed as number of cells that were infected (EGFP-
positive), as a percentage of the number of cells that were infected
by the WT virus (Figure 2A, B). Additionally, to allow for the
isolation of temperature sensitive mutants that could facilitate the
subsequent characterization of the replication defects associated
with CA mutations (see below), this viability screen was carried out
at two temperatures, 35uC (Figure 2A) and 39.5uC (Figure 2B).
Virtually all of the viral clones containing WT CA sequence, or
only silent mutations, replicated at levels close to that of the
Figure 1. Generation and characterization of the CA mutant library. (A) Schematic representation of the replication competent HIV-1
proviral plasmid pNHGcapNM used in this study. NotI and MluI restriction sites flank a region of Gag that includes nearly all of CA, and a few amino
acids in MA. This 717 bp sequence was subjected to Genemorph II mutagenesis and subcloned into pNHGcapNM. (B) Distribution of the number of
nucleotide changes in each clone for the resulting library (this includes sequences that were represented more than once). (C) Distribution of the
number of amino acid changes in each clone in the library (this includes sequences that were represented more than once, nonsense mutations,
mutations in MA and frameshifts). (D) Pie chart describing all of the resulting single amino acid changes. SINGLE clones were those included in further
studies of the library, and the remaining clones were discarded for the following reasons: STOP (mutation resulted in a stop codon), MA (contained a
mutation in the small fragment of MA included in the amplicon), FS (frameshift), DUP (duplicate mutation of clone already in library).
doi:10.1371/journal.ppat.1003461.g001
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Figure 2. Fitness effects of mutations in the CA mutant library. (A) Viability of all CA mutant clones at 35uC (this excludes nonsense
mutations, duplicates, frameshifts, MA mutations), demonstrating how the number of amino acid mutations in CA affects fitness (Replication is
plotted as the fraction of MT-4 cells that are GFP+ (infected), as a percentage of the fraction infected by WT virus following a spreading replication
assay). (B) Viability of all CA mutant clones at 39.5uC (this excludes nonsense mutations, duplicates, frameshifts, MA mutations), measured as in (A). (C)
Distribution of mutational fitness effects (DMFE) for all single amino acid CA substitution mutants at 35uC. (D) DMFE for all single amino acid CA
substitution mutants at 39.5uC.
doi:10.1371/journal.ppat.1003461.g002
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starting construct. This indicated that the frequency with which
defective viruses were generated by cloning artifacts or silent
mutations was extremely low (Figure 2A, B). Moreover, this
analysis revealed CA to be extremely fragile, or intolerant of
randomly introduced amino acid substitutions (Figure 2A, B). If
the cut-off for being viable is arbitrarily set at 2% of the parental
virus replicative fitness, only 35% and 28% of the 135 clones that
encoded single amino acid substitutions were viable at 35uC and
39.5uC respectively. These figures could overestimate the propor-
tion of mutants that might be expected to be fit in vivo, as
requirements for replication in an infected individual might be
more stringent than in highly permissive MT-4 cells, and 2% of
WT virus fitness in MT-4 cells is a rather generous cut-off figure
for a designation of ‘viable’. Increases in the number of amino acid
substitutions further decreased the frequency of viable mutants;
only 6% and 3% of the 125 clones containing two random amino-
acid substitutions were viable at 35uC and 39.5uC respectively.
Only 1 of 73 clones containing 3 random amino acid substitutions
was viable, and none of the 45 library clones with four or five
random substitutions could replicate at all.
Analysis of single amino acid CA mutants
In total, the subset of mutants that had a unique single amino
acid substitution within CA (135 mutants) covered 102 (44%) of
the 231 CA residues (for 33 CA residues there was more than one
unique mutation at each position). To refine our estimate of CA
robustness, two more assays were conducted at a natural
temperature of 37uC, using only the panel of CA mutants that
had unique single amino acid substitutions. First, in the MT-4
spreading assay, 40 mutant viruses (30%) exhibited at least 2% of
parental virus fitness, and are listed in Table 1. Conversely, Table 2
contains the longer list of 95 mutants that had less than 2% of WT
fitness in the spreading infectivity assay, and are considered non-
viable. Single-cycle infectivity was also measured by transfecting
293T cells with proviral plasmids and measuring infectivity using a
larger dose of virus (equivalent to an MOI ,1 for the parental
clone) and treating the MT-4 cells with dextran sulfate 16 h post-
infection to limit replication to a single-cycle. Replicative fitness in
spreading versus single-cycle assays was well correlated (Table 1),
although most mutant viruses fared better in the single-cycle assay
than in the spreading assay. This phenomenon possibly reflects the
effect of transfection in the single-cycle assay, whereby overex-
pression of the viral proteins may suppress defects, as opposed to
the spreading infection assay where more natural levels of viral
gene expression are attained. Alternatively, the multiple rounds of
replication in the spreading assay might amplify the effect of a
defect in the single-cycle assay.
Most of the viable CA mutants displayed attenuated infectivity,
with 89% of single amino acid substitution causing a greater than
2-fold reduction in infectious virion yield. This suggests that it is
difficult to improve upon the fitness of the parental CA, and that
perhaps the parental CA sequence is close to a fitness peak. In
previous analyses of panels of single amino acid mutants of RNA
viruses, the distributions of mutational fitness effect (DMFE) values
were bimodal in nature, with substitutions causing either lethality,
or only minor decreases in fitness [4–9]. This phenomenon was
observed to some extent for HIV-1 CA (Figure 2A–D). However,
the proportion of viable mutants was significantly smaller than has
been observed in previous studies [4–9], and the selective
occurrence of mutants with only minor fitness defects was not
prominent (Figure 2A–D).
A comparison of the Tables 1 and 2 reveals that different
mutations at certain positions in CA, such as I2, can result in
markedly different fitness effects, suggesting that the type of
residue change may, in some cases, be of some importance in
determining fitness. However, inspection Tables 1 and 2 indicates
that this was not typically the case, and the position within CA
rather than the type of residue change appeared generally more
important in determining the effect of mutations on fitness. Of the
231 amino acids that comprise CA, 56.3% lie within CA’s 11
helices, 5.6% are in the N-terminal b-strand, 3.9% are in the
cyclophilin A binding loop, and the remaining 34.2% are in other
inter-helical ‘loops’. These numbers can be used to provide
context to the summary of mutant fitness values to indicate regions
of particular genetic fragility in CA (Table 3, Figure 3A). Notably,
the N-terminal b-strand, the cyclophilin binding loop, and
interdomain linker appeared comparatively robust, with 70–
100% of mutants in these regions retaining some viability. In
contrast, helices were less tolerant of mutation, with a mere 16% of
mutants in these domains retaining some viability, while the
interhelical loops, where 39% of mutants retained viability, had
intermediate robustness. Helices 2, 5, 6, and 7 were particularly
fragile, with all 25 mutations in these sequences causing non-
viability. A graphical representation of these results, where the
fitness of each mutant is plotted against its position in the linear
CA sequence (Figure 3A), confirms that regions of mutational
fragility are non-uniformly distributed in CA, with mutations in
NTD helices being extremely likely to cause inactivation
(Figure 3A).
When displayed in the context of a capsid hexamer structure
(PDB: 3GV2, Figures 3B, C), amino acids corresponding to viable
mutants (in green, Figure 3B) appeared to occur preferentially in
surface exposed residues. Conversely, mutations in the interior of
the CA structure almost always generated non-viable mutants
(displayed in red, Figure 3C). This finding is particularly evident
when the CA hexamer is viewed from the point of view of interior
of the assembled capsid (Figure 3B,C, rightmost diagrams), and
reinforces the impression of an inner CA structure, or ‘core,’
composed of helices that are particularly sensitive to mutation.
Analysis of the solvent accessible surface area for individual
mutated residues confirmed these findings. Specifically, mutated
residues with solvent accessible surface areas of less than 50 A˚2 (an
appropriate cutoff for surface exposure based on previous
mutagenesis analyses [57]) caused significantly greater fitness
defects (p = 0.003). Viruses with such mutations and exhibited a
mean fitness value of 2.8% of WT. Conversely, viruses harboring
mutations of more surface exposed amino acids (solvent accessible
areas of greater than 50 A˚2) exhibited a mean fitness value of 18%
of WT.
Biological basis for genetic fragility in HIV-1 CA
As outlined in the introduction, CA performs a number of
functions in HIV-1 replication, including mediating the assembly
of immature virions (in the context of the Gag precursor) and
formation of a mature conical capsid. Moreover, a capsid of
optimal stability is thought to be important during the uncoating
step of the HIV-1 cycle in newly infected cells, and CA is also key
for the import of the viral genome into the nucleus of newly
infected cells. To determine which of these functions, if any,
contributed the genetic fragility of HIV-1 CA, we performed a
number of assays to elucidate the nature of the replication defects
in constitutively or conditionally non-viable CA mutants.
To facilitate the elucidation of the nature of the replication
defects in CA mutants, we first focused on the subset of
conditionally non-viable, ts mutants. At outlined in Figure 2,
initial determinations of mutant fitness were carried out at 35uC
and at 39.5uC. While most CA mutants were approximately
equally fit or unfit at both temperatures, a few exhibited a ts
Genetic Fragility in the HIV-1 Capsid
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Table 1. Fitness measurements for viable HIV-1 CA mutants.
HIV CA mutant Location in CA
Single cycle infectivity
(% of WT)a
Spreading fitness
(% of WT)b
Frequency in subtype B
isolates (%)c
I2L b-strand 90 66 0.1
N5D b-strand 20 5 0.2
I6T b-strand 52 57 0
M10I b-strand 19 3 0.1
M10L b-strand 74 27 0
M10V b-strand 11 16 0.1
Q13H b-strand 27 6 4.2
A14S Loop 77 81 2.9
A14T Loop 98 87 1.2
I15V Loop 32 14 0.3
N21S Helix 1 56 47 0
S33C Loop 40 48 0
Q50H Helix 3 20 3 5.3
E75D Helix 4 41 22 5.8
V83M Helix 4 75 65 2.6
H87Q Cyclophilin b.l.* 120 92 13.7
H87R Cyclophilin b.l. 28 2.5 0.2
I91T Cyclophilin b.l. 85 77 0
I91V Cyclophilin b.l. 100 82 41.3
M96I Loop 120 92 11.6
E98D Loop 101 63 5.1
R100S Loop 54 43 0
S146C Loop 44 34 0
T148I Loop 66 37 0
S149C Loop 65 74 0
S149G Loop 71 30 0.2
I150V Loop 19 3 0.2
I153T Loop 21 5 0.4
Y164F Helix 8 64 31 0
R167Q Helix 8 11 6 0
A177S Loop 99 37 3.0
M185I Helix 9 24 3 0
E187V Helix 9 60 47 0
L190M Loop 38 33 0.1
T200S Helix 10 104 90 1.6
A204G Helix 10 77 89 8.7
G208E Loop 15 4 0
A209T Loop 108 94 0
A209V Loop 72 84 0.1
T216A Helix 11 72 38 3.0
aInfectivity measurement in which MT-4 cells were inoculated with supernatant from 293T cells (equivalent to MOI = 1 for WT virus) that had been transfected with
single residue CA mutant proviral plasmids. Dextran sulfate was added approximately 16 h after infection to restrict replication to a single cycle. Values are reported as
the percentage of the number of infected (GFP+) cells obtained with the WT virus.
bFitness measurement in which MT-4 cells were inoculated with supernatant from 293T cells (equivalent to MOI = 0.01 for WT virus) that had been transfected with
single residue CA mutant proviral plasmids. Multiple cycles of replication were permitted over 72 h. Values are reported as the percentage of the number of infected
(GFP+) cells obtained with the WT virus.
cThe frequency at which the indicated mutant residue occurs in 1000 HIV-1 subtype B sequences.
*Abbreviation for cyclophilin binding loop.
Mutants were considered viable if they maintained or 2% of WT fitness in the spreading replication assay.
doi:10.1371/journal.ppat.1003461.t001
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phenotype that was quite large (Figure S1). Some of the ts mutants
(circled in Figure S1 and listed in the materials and methods)
included double mutants. We therefore generated CA mutants
that encoded each single amino acid substitution in isolation.
Ultimately, this yielded eleven single amino-acid CA mutants with
substantial ts replication phenotypes.
Because the initial screen measured replicative fitness over
multiple rounds of replication, it could not determine what specific
step in the viral life cycle was impaired in the constitutively or
conditionally non-viable mutants. We therefore determined the
single-cycle infectivity of the ts CA mutants using virions generated
in 293T cells at 35, 37, or 39.5uC, which were then used to infect
MT-4 cells at 35, 37, or 39.5uC (Figure 4A, B). Importantly, the
WT control, pNHGcapNM, maintained a consistent viral titer
regardless of production and infection temperatures (Figure 4).
Most of the ts CA mutants had similar, or modestly reduced,
infectivity as compared to the parental virus when virion
production and infection was done at the permissive temperature
(35uC). Strikingly however, single-cycle replication of all the ts
mutants was inhibited at least 50 to 1000-fold when restrictive
temperatures were applied during virion production (Figure 4A,
B). Conversely, all of the ts mutants were completely unaffected
when restrictive temperatures were applied only during infection
and not during production (Figure 4A, B). This result indicated
that the defects associated with conditionally non-viable ts CA
mutants occurred exclusively and irreversibly, during or shortly
after, particle production, and not during early steps of the viral
life cycle (e.g. uncoating or nuclear import).
Analysis of Gag expression and processing by the WT virus and
the ts CA mutants revealed that similar levels of cell-associated
Gag precursor Pr55 and capsid p24 were present regardless of the
Table 2. Non-viable HIV-1 CA mutants.
CA mutants
in NTD Location in CA
CA mutants
in CTD Location in CA
I2T b-strand I153M Loop
H12R b-strand E159V Loop
Q13R b-strand F161C Helix 8
S16P Loop D163G Helix 8
R18G Helix 1 V165A Helix 8
N21Y Helix 1 F168S Helix 8
K25I Helix 1 R173I Helix 8
V26E Helix 1 A174G Loop
K30E Loop K182Q Helix 9
K30N Loop W184L Helix 9
F32L Loop W184R Helix 9
F32S Loop T186A Helix 9
S33I Loop L190S Loop
P34S Helix 2 A194V Loop
V36A Helix 2 N195S Loop
M39T Helix 2 I201N Helix 10
M39V Helix 2 L211I Helix 11
F40L Helix 2 E212D Helix 11
F40Y Helix 2 M214L Helix 11
L43I Helix 2 M215V Helix 11
G46R Loop A217V Helix 11
P49L Helix 3 Q219P Loop
L52F Helix 3 G220V Loop
N57S Helix 3 V221A Loop
V59A Loop K227I Loop
V59M Loop K227N Loop
G60W Loop K227R Loop
Q63R Helix 4
A65V Helix 4
M66I Helix 4
M66V Helix 4
M68L Helix 4
M68T Helix 4
L69I Helix 4
I73N Helix 4
A77D Helix 4
W80R Helix 4
P90T Cyclophilin bl
Q95L Loop
Q95R Loop
M96T Loop
P99A Loop
P99L Loop
R100W Loop
S102R Helix 5
A105G Helix 5
T110I Loop
L111F Helix 6
E113V Helix 6
Table 2. Cont.
CA mutants
in NTD Location in CA
CA mutants
in CTD Location in CA
I115K Helix 6
I115L Helix 6
I115T Helix 6
M118L Helix 6
M118V Helix 6
H120P Loop
N121I Loop
I124N Loop
V126A Helix 7
I129M Helix 7
I129T Helix 7
Y130C Helix 7
Y130H Helix 7
R132G Helix 7
G137E Helix 7
L138I Helix 7
M144V Helix 7
L151I Loop
L151Q Loop
Mutants were considered non-viable if they exhibited ,2% of WT fitness in the
spreading replication assay as described in Table 1.
doi:10.1371/journal.ppat.1003461.t002
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Figure 3. Distribution of single amino acid substitutions in CA and their effects on fitness. (A) Plot of HIV-1 fitness values for CA mutants
with the location of the mutation arranged on the X-axis from left (N-terminal residue) to right (C-terminal residue), and their corresponding fitness
(as a % of WT in a spreading replication assay) as described in Tables 1 and 2. (B, C) Location of single amino acid mutations in an X-ray crystal
structure of the CA hexamer (PDB: 3GV2). Leftmost images show the hexamer viewed from the exterior of the intact capsid, center images show the
hexamer viewed from within the plane of the capsid lattice and rightmost images show the hexamer viewed from the interior of the intact conical
capsid. Residues that gave greater than 2% of WT fitness in a spreading replication assay when mutated (viable mutants) are shown in green (B).
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production temperature (Figure 5A). However, unlike the WT
control, each of the ts CA mutant viruses generated 57% to 88%
less extracellular virion-associated p24 at the restrictive temper-
ature (Figure 5A). Because it was possible that the mutations
could have affected the CA protein stability or recognition by the
p24 antibody, we also analyzed Gag expression, processing and
particle generation by the ts mutants using an anti-p17 matrix
(MA) antibody (Figure 5B). This analysis yielded similar results.
Specifically, there were approximately uniform levels of p17 in
cell lysates for each of the ts CA mutants regardless of
temperature. However, reductions in extracellular particulate
p17 protein of 2.4–25-fold indicated that particle production was
decreased by 59–96% for the ts mutants at the nonpermissive
temperature.
Although the 2.3 to 25-fold reduction in particle production
observed for the ts CA mutants is smaller than the corresponding
50 to 1000-fold reductions in infectious virion yield, it is important
to note that the majority of this reduction in infectivity (specifically
57% to 96%) was due to the inability of these mutants to efficiently
generate particles. However, because the block in the generation
of extracellular particles was not absolute, and there was residual
generation of poorly infectious particles, it appeared that particle
formation by the ts mutants was attenuated to varying degrees at
the non-permissive temperature rather being than completely
defective. The inability of the ts mutants to efficiently generate
virions at the restrictive temperature is entirely consistent with the
finding that it was the temperature during virion production, not
inoculation, that determined the phenotype of all of the ts mutants
we identified, and that all these mutations conferred defects that
are manifested during virion morphogenesis.
Careful inspection of both anti-CA and anti-MA blots of the ts
mutants at the nonpermissive temperature revealed a slight
abnormality in Gag processing. The parental virus appeared to
generate a single ,41 kDa band that reacted with anti-CA and
anti-MA at both permissive and restrictive temperatures (pre-
sumptively the p41 MA-CA-p2 processing intermediate,
Figures 5A and 5B). Conversely, one or sometimes two additional
protein species, of similar but not identical mobility to p41 were
observed for each of the ts mutants, specifically at the restrictive
temperature. Thus, for each of the ts CA mutants, attenuated
particle formation was accompanied by perturbation of Gag
processing, which may have contributed to the overall defects in
particle yield and infectiousness. Notably, eliminating viral
protease activity eliminated the temperature-induced reduction
in particle yield for all eleven ts CA mutants (Figure 5C). Thus,
capsid mutations that caused temperature-dependent attenuation
of particle formation do not do so prior to protease activation. This
being so, and because inoculation temperature did not affect
infectivity, it appeared that all eleven conditionally non-viable CA
mutants have defects that are manifested during, and not before or
after, virion morphogenesis.
Most constitutively non-viable CA mutants exhibit
attenuated particle formation
The above analysis of the eleven conditionally non-viable CA
mutants suggested that requirements imposed during particle
Residues that gave less than 2% of WT fitness in a spreading replication assay when mutated (non-viable mutants) are shown in red (C). (D)
Comparison of fitness and residue exposure, using solvent accessible surface area (determined using UCSF Chimera with PDB 3GV2). Mutated
residues were placed in two groups that had either (i) a solvent accessible surface area ,50 A˚2 or (ii) a solvent accessible surface area .50 A˚2. The
corresponding fitness measurement for each mutant is plotted.
doi:10.1371/journal.ppat.1003461.g003
Table 3. Summary of CA mutant viability by CA region.
Region Number of viable mutants Number of non-viable mutants % Viable mutants
b-strand 7 3 70
Helix 1 1 4 20
Helix 2 0 7 0
Helix 3 1 3 25
Helix 4 2 10 17
Cyclophilin b.l. 4 1 80
Helix 5 0 2 0
Helix 6 0 7 0
Helix 7 0 9 0
Helix 8 2 5 29
Helix 9 2 4 33
Helix 10 2 1 67
Helix 11 1 5 17
MHR 3 6 33
Interdomain linker 5 0 100
Helices (all) 11 57 16
Loops (all) 22 35 39
NTD 27 68 28
CTD 13 27 33
doi:10.1371/journal.ppat.1003461.t003
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Figure 4. Conditionally viable (ts) CA mutants exhibit defects only when assembled at the non-permissive temperature. (A)
Measurement of infectious virion titer from 293T cells transfected with either the parental or the ts single residue mutant proviral plasmids, and
placed at either 35uC (filled circles), 37uC (filled squares), or 39.5uC for virion production (filled triangles), as indicated by distinct plot lines. The titer of
infectious virus in the resulting supernatants from each mutant was measured in MT-4 cells at 35, 37, or 39.5uC as indicated on the x-axis, with the
addition of dextran sulfate at approximately 16 h post-infection to limit replication to a single cycle. Note that some single ts mutants were resolved
from double or triple mutants (see Materials and Methods) so do not appear in Table 1 or 2. (B) As in (A), however, here the temperature of virus
production is indicated on the x-axis, and inoculations were done in MT-4 cells at 37uC only.
doi:10.1371/journal.ppat.1003461.g004
Genetic Fragility in the HIV-1 Capsid
PLOS Pathogens | www.plospathogens.org 10 June 2013 | Volume 9 | Issue 6 | e1003461
Figure 5. All ts CA mutants exhibit protease-dependent reduction in extracellular particle yield at the non-permissive temperature.
(A). Western blot analysis (using an anti-CA antibody) of cell lysates and virions generated by transfected 293T cells. Two lanes are shown for each
mutant: on the left is the sample from cells that were incubated at 35uC following transfection (Lo) and on the right is the sample from cells that were
incubated at 39.5uC following transfection (Hi). Numbers below each lane indicate fluorescence intensities (LiCOR) associated with the CA protein
pelleted from virion-containing supernatant. (B) Western blot analysis using an anti-HIV-1 MA antibody (p17) of cell lysates and virions, for the same
panel as shown in A. Numbers below each lane indicate fluorescence intensities (LiCOR) associated with the MA protein pelleted from virion-
containing supernatant. (C) Western blot analysis for the same panel of ts CA mutants as in A, but expressed in the context of a protease-defective
proviral plasmid. Numbers below each lane indicate fluorescence intensities (LiCOR) associated with the CA protein pelleted from virion-containing
supernatant.
doi:10.1371/journal.ppat.1003461.g005
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production, and not during any other phase of the viral life cycle,
are responsible for the mutational fragility of HIV-1 CA.
However, it was possible that the selection of conditionally rather
than constitutively non-viable mutants could have biased this
conclusion. Thus, we examined the ability of the larger set of 81
constitutively non-viable mutants to generate extracellular parti-
cles, using western blot assays (Figure 6A).
Most (74%) of the constitutively non-viable mutants exhibited a
greater than 5-fold reduction in the yield of extracellular particles.
A minority (20%) of these lethal mutations did not affect the
magnitude of particle production (less than 2-fold changes in
particle yield), but instead resulted in the efficient generation of
non-infectious particles (Figure 6C). The remaining 6% of mutants
gave intermediate phenotype with 2- to 5-fold reductions in
Figure 6. Most non-infectious constitutively non-viable CA mutants exhibit attenuated particle formation. (A) Western blots, probed
with an anti-CA antibody, of cell lysates and virions for all constitutively non-viable CA mutants (those exhibiting ,2% of WT fitness in a spreading
replication assay). It should be noted that multiple substitutions between residues 159 and 168 resulted in diminished signal using the monoclonal
anti-CA antibody (derived from hybridoma 183-H12-5C). Indeed CA carrying an R167Q mutation is infectious, but is not recognised by this antibody
(unpublished observations) indicating that the epitope of the antibody lies in this region. This suggests that the E159V substitution (Figure 6A) might
also disrupt antigen recognition, accounting for the absence of signal in this lane. (B) Location of mutations in the CA hexamer that are constitutively
non-viable but exhibit near WT levels of particle formation. The leftmost image shows the hexamer viewed from the exterior of the intact conical
capsid, the center image shows the hexamer viewed from within the plane of the conical capsid lattice and the rightmost image shows the hexamer
viewed from the interior of the intact conical capsid.
doi:10.1371/journal.ppat.1003461.g006
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particle yield. In a few instances, for example at residues K30,
M39, and I115, a change to one amino acid resulted in efficient
generation of extracellular particles that were non-infectious, while
a change to another amino acid resulted in attenuated particle
production. Nonetheless, there did not appear to be any general
trend in changes of amino acid properties that might cause
mutants to efficiently generate non-infectious virions as opposed to
being attenuated for particle generation. Nearly all of the mutants
that yielded WT levels of non-infectious particles mapped to the
inner core of the hexamer, in a manner that was similar to the
general distribution of inactivating CA mutations (compare
Figures 6B and 3C). Of note, many constitutively non-viable
mutants displayed evidence of perturbed processing, with the
generation of additional ,40 kDa Gag protein species, similar to
observations with the conditionally non-viable mutants at the
restrictive temperature (Figure 5 A, B). Overall, these data
reinforce the conclusion that the primary underlying cause of
mutational fragility in HIV-1 CA is the need to mediate accurate
and efficient particle assembly.
Reduced particle formation in most conditionally and
constitutively non-viable CA mutants
To further examine the nature of the defects in conditionally
and constitutively non-viable CA mutants, we employed electron
microscopy (EM) to quantify and visualize particle morphogenesis.
To examine the ts CA mutant mutants, 293T cells (at 39.5uC)
were transfected with the parental or one of six randomly selected
ts CA mutant proviral plasmids, plus a plamid expressing a
modified Vpu-resistant human tetherin (delGI, T45I) [58] to
retain virions at the plasma membrane and facilitate their
visualization. Inspection of 150 cells for each ts CA mutant clearly
showed these mutants generate far fewer total particles at the
restrictive temperature (Figure 7A shaded bars), with reductions
ranging from 4- to 221-fold (75–99.5% fewer particles). Some, but
not all particles generated by the ts CA mutants appeared
morphologically normal, but there appeared to be a higher
fraction of abnormal particles and budding structures as compared
to the parental virus (Figure 7B). However, the rarity with which
the ts CA mutants generated discernable viral structures made it
difficult to reach definitive conclusions about the morphological
accuracy (or otherwise) of the particles that were formed.
We also performed thin-section EM analyses of cells transfected
with three randomly selected constitutively non-viable mutants
(K25I, L52F, and N195S) that exhibited reduced extracellular
particle yield (Figure 7C,D). Again, this was done in the presence
of tetherin (delGI, T45I) to facilitate particle imaging. This
analysis revealed reductions in particle formation that were similar
in character to those observed for the conditional ts CA mutants.
Specifically, particle formation for these mutants was reduced ,6
to 28-fold (82–96% fewer particles) as compared to the parental
virus. The small number of particles that were generated by the
K25I and L52F mutants appeared morphologically similar to the
parental virus, while the rare budding structures generated by the
N195S mutant were obviously irregular (Figure 7D). Interestingly,
defects similar to that exhibited by N195S have been previously
reported for CA mutations made at a nearby residue (D197) [56].
As an additional control for these experiments, particle
formation by a constitutively non-viable mutant (G60W) that
gave high levels of non-infectious particulate p24 in the western
blot assay was quantified by EM analysis. In fact, the G60W
mutant generated particles that were as, or even more, numerous
than the parental virus. Overall, the data acquired via EM analysis
of particle formation broadly corroborated the estimates of particle
formation efficiency obtained using western blot assays (Figures 5A,
5B and 6A), and reinforce the notion that most randomly
introduced CA mutations induced substantial attenuation, but
not complete abolition, of particle formation.
Because a fraction (20%) of the constitutively non-viable CA
mutants generated normal levels of extracellular particles that
were non-infectious, we randomly selected three such mutants,
(R18G, G60W, and M215V) for examination by thin-section EM
(Figure 7E). Each of these mutants exhibited morphologies that
were indistinguishable from the WT virus. Additionally, cell free
virions produced by these mutants, plus one additional non-viable
mutant (K30N) that also exhibited efficient particle formation,
were also examined by cryo-electron microscopy (Figure 7F). This
analysis again revealed particle morphologies that were similar to
WT, with the possible exception of G60W, whose cores were more
difficult to discern.
Only a small fraction of randomly introduced CA mutants
affect HIV-1 infection of non-dividing cells
The above data demonstrates that a large fraction of randomly
introduced mutations impair the ability of HIV-1 CA to support
efficient and accurate virion morphogenesis. To determine whether
a similarly large fraction of CA mutants affected another critical
function of CA, namely infection of non-dividing cells [31], we
screened all CA mutants that exhibited easily measurable infectivity
in single-cycle infection assays for their ability to infect cells in the
presence or absence of aphidicolin (which arrests the cell cycle in S-
phase). Only one of the 58 mutant viruses tested, N57S, exhibited
substantially higher infectivity in the absence than in the presence of
2 mg/ml aphidicolin (Figure 8). A mutation at this position, N57A,
has previously been reported to impose cell cycle dependence on
HIV-1 infection [30]. Because only one of the 58 randomly
introduced mutations tested affected the cell cycle independence of
HIV-1 infection, these data suggest that CA sequence is constrained
to a large extent by the need to accurately and efficiently assemble
into functional viral particles, but to only a small extent by another
key function, i.e. the need to infect non-dividing cells.
Comparison of naturally occurring and randomly
introduced CA mutations
Our measurements of in vitro fitness of HIV-1 CA mutants
suggested that fitness should place tight constraints on the
sequences of CA that are found in natural populations. Therefore,
to compare the fitness of single amino acid HIV-1 CA mutants
with their occurrence in vivo, we obtained a set of 1,000 CA
sequences isolated from HIV-1 subtype B infected individuals, and
determined the frequency with which mutations in our random
mutant library were found in these naturally occurring sequences.
A plot of the frequency with which CA mutations occur in natural
populations against their measured in vitro fitness (Figure 9A)
revealed that only mutants that exhibited a fitness of at least 40%
of the WT CA sequence in our in vitro assays occurred at a
frequency greater than 1% in natural populations. Curiously,
however, the nineteen random mutants that exhibited .40% of
parental virus fitness had bimodal distribution of occurrence in
vivo. Some occurred relatively frequently (i.e. in .3% of natural
sequences Figure 9B), while others occurred extremely rarely
(,0.3% of natural sequences Figure 9C). That is to say that a
subset of mutations that incur little or no apparent fitness cost
appear to be largely absent from natural populations of subtype B
HIV-1. Consistent with their lack of effect on fitness, virtually all of
these apparently innocuous, but rare, mutations occurred on the
outer surfaces of the hexamer, and avoided the inner hexamer
core (Figure 9D).
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Figure 7. Electron microscopic analysis of particle formation by selected conditionally and constitutively non-viable CA mutants.
(A) Analysis of thin-section EM images showing parental virus and ts CA mutant particle production at the restrictive temperature (39.5uC) in 293T
cells. Circles represent the number of particles associated with individual cells (n = 150 for each sample), while shaded bars demonstrate the total
number of particles counted in the150 cells. (B) Representative images of the thin-section EM samples analysed in (A). Scale bars shown apply to all
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CA mutations that exhibit high fitness in vitro but occur
rarely in vivo do not exhibit replication defects in primary
cells
The existence of a subset of mutations that gave high fitness in
MT-4 cells in vitro, yet were virtually absent in natural populations,
suggested that some mutations may be selected against in vivo in a
manner that was not revealed by our fitness assays. Previous
studies have demonstrated that CA mutations can have cell-type
dependent effects on HIV-1 infectiousness [38,39,59,60], and it
was therefore possible that these mutants might exhibit fitness
defects that are manifested in natural target cells, but not in MT-4
cells. Thus, we performed replication assays in primary cell types
using 8 apparently fit viruses containing mutations that occurred
rarely in natural populations (Figure 9C) and 5 randomly chosen
viruses containing mutations that occurred frequently (Figure 9B).
In fact, there was no significant difference between the ability of
the rarely occurring or frequently occurring CA-mutant viruses to
infect PBMC, primary CD4+ T cells or macrophages in short term
(quasi single-cycle) infection assays (Figure 10A, B, C). Further-
more, there was no difference in the capacity of the rarely and
frequently occurring mutants to replicate in a spreading infection
assay in PBMC (Figure 10C). These results suggest that the rarity
of apparently fit CA mutant viruses in natural HIV-1 subtype B
populations is not due to differences in their capacity to replicate
in primary cells. Rather, this finding suggests the presence of some
unknown selective pressure that allows some intrinsically fit CA
variants, but not others, to persist in vivo.
Selective pressures that occur in vivo select sequence
changes in the most genetically fragile domains of HIV-1
CA
To further examine the relationship between the impact of CA
mutation on in vitro fitness and occurrence in natural HIV-1
subtype B populations, we next compared naturally occurring
variability across the CA sequence (as measured by Shannon
entropy value) with the propensity of CA domains to tolerate
mutation. The expectation was that regions that are more robust
(Figure 3A) should exhibit higher variability in natural popula-
tions. Like a previous analysis of the Shannon entropy of the N-
terminal of subtype C HIV-1 [43], this analysis revealed regions of
high entropy in CA (.0.4) while other regions were more
conserved (Figure 11A). There was a degree of accord between the
ability of CA domains to tolerate mutation and Shannon entropy
values. For example, there were shared regions of comparatively
high robustness and high entropy, such as the cyclophilin binding
loop and regions encompassing residues ,5 to ,35, and ,175 to
,210. Additionally, there were regions where especially low
robustness coincided with regions of low variability in vivo, such as
in CA helices 2 and 3, and also in the MHR (Figure 11A).
However, there were also significant discrepancies between the
Shannon entropy and robustness profiles across CA. For example,
in helices 5, 6, and 7 (from residues 101 to 145), Shannon entropy
values were often quite high, but fitness measurements revealed
this region to be highly genetically fragile. This finding strongly
suggests that selective pressures in addition to fitness act on the
HIV-1 CA sequence in vivo.
One such selective pressure is likely imposed by the adaptive
immune system, particularly cytotoxic T-lymphocytes (CTLs) that
can recognize peptides derived from HIV-1 CA. Indeed, several
studies have demonstrated that mutations in CA can be driven by
selective pressures imposed by CTLs [43–46]. Moreover, some of
these studies have indicated that immune responses to particular
epitopes in CA are protective, in that their appearance correlates
with slower disease progression. For example, the oft studied
protective HLA-B*57-restricted epitopes KF11 (residues 30–40)
and TW10 (residues 108–117), and the B*27 restricted epitope
KK10 (residues 131–140), all occur in regions of apparently
extreme genetic fragility (Figure 11A, Table 2). In fact, a
comparison of the DMFE values for the 41 library mutations that
occurred in so-called protective epitopes [specifically QW11
(residues 13–23), IW9 (residues 15–23), KF11 (residues 30–40),
TL9 (residues 48–56), EW10 (residues 71–80), TW10 (residues
108–117), DA9 (residues 166–174), KK10 (residues 131–140)]
with 94 library mutations that occurred outside these epitopes,
suggested that protective epitopes occur in regions of CA that are
more genetically fragile than remaining CA sequence (Figure 11B).
Indeed, the mean fitness value for mutations occurring within
these ‘protective’ epitopes was 7.9% of WT while the mean fitness
value for mutations occurring outside these epitopes was 15.1% of
WT.
Summary of the fates of CA mutations
The scope of the mutagenesis carried out in this study, in which
almost half of the amino acids in CA were individually mutated,
coupled with an analysis of the frequency with which these
mutations are present in natural populations, should allow
generalized predictions of the fate of randomly introduced single
nucleotide (Figure 12A) or single amino acid (Figure 12B)
substitutions into CA. In the case of random nucleotide changes
(Figure 12A), 22% should give synonymous changes that, in the
great majority of cases, should not affect fitness (Figure 2). If there
images. (C) Analysis of thin-section EM images, as in A, showing parental virus and constitutively non-viable CA mutant particle formation at 37uC.
Particles associated with 150 cells for each sample were counted and plotted as in A. (D) Representative images of the thin-section EM samples
analysed in (C). Scale bars shown apply to all images. (E) Representative thin-section EM images for three constitutively non-viable CA mutants that
yielded high levels of non-infectious particles. (F) Cryo-EM images of purified virions from parental virus and four constitutively non-viable CA
mutants that yielded high levels of non-infectious particles.
doi:10.1371/journal.ppat.1003461.g007
Figure 8. Most CA mutants do not exhibit cell cycle dependent
infectivity defects. The infectivity of 58 CA mutants exhibiting readily
measurable infectivity in a single cycle assay was measured using
untreated TZM-bl target cells (x-axis), and following arrest of the cell
cycle with aphidicolin (arrests cell cycle in the S-phase) at 2 mg/ml (y-
axis).
doi:10.1371/journal.ppat.1003461.g008
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Figure 9. Occurrence of CA mutations in natural HIV-1 subtype B populations. (A) Plot of the frequency with which the library mutations
occur in 1000 natural HIV-1 subtype B CA sequences (Y-axis) versus the fitness of the same mutations in a spreading replication assay (X-axis). The
vertical dashed line indicates 40% of WT replicative fitness, below which mutants rarely occurred in nature. Mutants that exhibited less than 0.01% of
WT infectivity, and were never observed in nature would appear at the origin of this graph and are not plotted. (B) List of the library mutants that
occurred at a frequency greater than 3% in 1000 subtype B isolates, and their corresponding fitness values. (C) List of the library mutants with greater
than 40% of WT fitness that occurred infrequently (,0.3%) or never in 1000 subtype B sequences, and their corresponding fitness values. (D).
Location of residues in the CA hexamer where mutations resulted in minimal fitness costs (.40% of WT replication) but that occurred in less than
0.3% of subtype B isolates. The leftmost image shows the hexamer viewed from the exterior of the intact conical capsid, the center image show the
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was no negative selection pressure in vivo other than fitness, then
10% of nucleotide substitutions are expected to yield a nonsynon-
ymous change that is sufficiently replication competent (40% of in
vitro WT fitness) to be potentially capable of flourishing in natural
populations. However, if, as suggested by the data in Figure 9, it is
true that only a fraction of mutations that yield variants with
.40% of WT in vitro fitness are capable of persisting in vivo, then
only 4% of all nucleotide substitutions are expected to yield non-
synonymous changes that would flourish in a natural setting.
If only nonsynonymous nucleoside substitutions are considered
(Figure 12B), then 87% are expected to be non-viable, with most
mutations (59%) inducing a .5-fold attenuation of particle
formation and a smaller fraction (21%) resulting in the generation
of particles (at least 20% of the level of WT) that are non-
infectious. Only 13% of nonsynonymous mutations are predicted
to be sufficiently replication competent (at least 40% of WT fitness)
to be potentially capable of flourishing in vivo, based on
measurements of intrinsic fitness. Given the finding that only a
fraction of intrinsically fit mutants actually persist in vivo, these data
suggest that only 5% of all CA amino acid substitutions are
actually expected to thrive in a natural setting.
Discussion
The goal of this study was to generate a reasonably sized sample
of random mutations in the CA protein that might arise naturally
during HIV-1 replication, and examine their biological effects. In
so doing, we could determine the genetic robustness of HIV-1 CA
and correlate the effect of amino acid substitutions in vitro with
their occurrence in natural viral populations. Moreover, such a
large library constitutes a resource for investigating various
functions and properties of the HIV-1 capsid. Our results uncover
a rather extreme genetic fragility in the HIV-1 CA protein, with a
large fraction (,70%) of individual, random amino acid substi-
tutions resulting in non-viable viruses (,2% of WT fitness).
Tables 4 and 5 place these findings in context. Specifically, Table 4
summarizes all previous studies of randomly mutagenized HIV-1
proteins (and domains thereof), as well as all other randomly
hexamer viewed from within the plane of the capsid lattice and the rightmost image shows the hexamer viewed from the interior of the intact
conical capsid.
doi:10.1371/journal.ppat.1003461.g009
Figure 10. ‘Rare but fit’ mutants behave indistinguishably from frequently occurring mutants in primary cells. (A) Percentage of
infected macrophages following infection with VSV-G pseudotyped WT virus (NHGcapNM, filled squares) or derivatives containing mutations that
occurred either frequently (filled triangles) or rarely (filled circles) in natural sequences, as indicated. (B) Percentage of infected stimulated CD4+ T
cells, as indicated. (C) Spreading replication, following infection of stimulated peripheral blood mononuclear cells with WT virus or derivatives
containing mutations that occurred either frequently or rarely in natural sequences, as indicated by the number of infected (GFP+) cells at the
indicated times, after infection at an MOI of 0.1.
doi:10.1371/journal.ppat.1003461.g010
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Figure 11. Correlation between fitness measurements and natural variation across the subtype B HIV-1 CA sequence. (A) Plot of
fitness HIV-1 for library CA-mutants, overlayed with the Shannon entropy values for every residue in capsid, derived from 1000 subtype B isolates. The
locations of the CA residues are arranged on the X-axis from left (N-terminal residue) to right (C-terminal residue), and their corresponding fitness (as
a % of WT in a spreading replication assay) and Shannon entropy values are plotted on the Y-axes. The location of so called ‘protective’ CTL epitopes
is indicated by horizontal blue lines. (B) Distribution of mutational fitness effects (DMFE) (at 37uC) for all single amino acid CA substitution mutants
that occurred in or outside the protective epitopes indicated in (A).
doi:10.1371/journal.ppat.1003461.g011
Figure 12. Summary of the effects of random mutations in HIV-1 CA. (A) Estimation of the frequency of various outcomes, based on in vitro
and in vivo data, for random single nucleotide substitutions (A) and random single amino acid changes (B). The charts indicate changes that are
synonymous (A only), nonsynonymous and nonsense (determined computationally using the CA sequence from pNHGcapNM). Mutants encoding
stop codons in CA were assumed to be non-viable and synonymous changes were assumed to be viable. Because only mutants with .40% fitness in
vitro are frequently observed in natural populations, this threshold was considered as sufficiently fit to thrive in vivo (the proportion of random
mutants that exhibit less than this 40% fitness threshold was estimated using data from Tables 1 and 2, and is indicated by the red circumferential
line). The proportion of mutants actually expected to thrive (nonsynonymous viable in vitro and in vivo) and expected not to thrive (nonsynonymous
viable in vitro only) was estimated using the data from Figure 9. The fate of the remaining mutants was estimated using the data from Figure 6
(nonsynonymous, non-infectious particles or nonsynonymous, attenuated (.5-fold deficit) particle formation).
doi:10.1371/journal.ppat.1003461.g012
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Table 4. Comparison of the robustness/fragility of CA with other viral sequences*.
Protein/Domain Fragility# Author Summary/Notes
HIV
HIV-1 capsid 70% Rihn et al. This study.
HIV-1 protease flap region (aa 46–56) 61% Shao et al. [87] 80 out of 131 mutants had negative activity, as shown by lack of
Western blot p66/p51 bands
HIV-1 protease 54% Parera et al. [88] A total 86% of 107 single mutants were deleterious to catalytic
efficiency, 54% lethal
HIV-1 protease 40% Loeb et al. [89] Out of 330 single missense mutants, around 40% were considered
sensitive to mutation.
HIV-1 reverse transcriptase palm
subdomain (aa 164–203)
28% Chao et al. [90] From 154 single mutants, 43 had RT levels that were #2% of WT
HIV-2 integrase 13% van den Ent et al. [91] 5 out of 38 mutants display severely attenuated integration.
HIV-1 reverse transcriptase motif B 12% Smith et al. [92] Using infectivity results, 3 out of 25 mutants had #2% of WT levels
HIV-1 transcriptional promoter (LTR) 0% van Opijnen et al. [93] None of the 15 single mutants diminished infectivity as much
as 2-fold in any cell line
HIV-1 reverse transcriptase
(aa 67–78 of beta3-beta4 loop)
0% Kim et al. [94] Fragility measured by genetic selection in E. coli, in which no
WT aa were essential
Other viral proteins/domains
Human Papilloma Virus 16 E1 63% Yasugi et al. [95] 5/8 single mutants were unable to replicate
Simian immunodeficiency virus mac239
envelope constant region 4
58% Morrison et al. [96] Only 11/26 single mutants were able to replicate appreciably
H3N2 influenza A hemaglutinin 56% Nakajima et al. [97] 44% of 248 single aa changes did not abrogate hemadsorption activity
H2N2 influenza A neuraminidase 53% Yano et al. [98] 47% of 152 single mutations in NA were tolerated, certain regions
were more sensitive
Bacteriophage l Cro 53% Pakula et al. [99] Approximately 37 out of 70 single residue mutants have #2%
of WT CRM levels
Mason-Pfizer monkey virus matrix 50% Rhee et al. [100] 4/8 single mutants had significant cell-free infectivity
Moloney murine leukemia virus capsid
central domain
40% Alin et al. [71] Virus replication was considered blocked based on RT levels
for 6 of 15 single mutants
Bacteriophage f1 gene V protein 35% Terwilliger et al. [101] Masso
et al. [102]
139 out of 371 single point mutants were inactive (unable to
inhibit E. coli growth)
Varicella-Zoster virus thymidine kinase 35% Suzutani et al. [103] Out of 17 single aa mutants, 6 resulted in a loss of enzyme activity
Bunyavirus nucleocapsid (N) 4–26% Eifan et al. [104] 5/115 single mutants had #2% WT mini replicon activity, 30/57
tested mutants had titers #2% of WT
Wheat streak mosaic virus HC-Pro 24% Stenger et al. [105] 6 out of 25 nonsynonymous substitutions abolished systemic infectivity
Bacteriophage T4 lysozyme 16% Rennell et al. [106] From 2015 single aa substitutions, 328 were deleterious enough to
prevent plaque formation
Mason-Pfizer monkey virus capsid MHR 15% Strambio-de-Castillia et al. [107] 2/13 single mutants have RT levels at #2% of WT, all other mutants
maintain at least 50%
Adenovirus VI 9% Moyer et al. [108] Only 1 out of 11 random single mutants led to a greater than
10-fold reduction in infectivity
Encephalomyocarditis virus internal
ribosome entry site
0% Van Der Velden et al. [109] Zero out of 13 single random mutants had significantly impaired in
vitro translation
Whole Viral Genomes
Tobacco etch potyvirus
(whole genome)
41% Carrasco et al. [9] Out of 66 single mutants, 41% were lethal and an additional 36%
were deleterious
Vesicular stomatitis virus
(whole genome)
40% Sanjua´n et al. [8] Fitness analysis of 91 single mutants showed a further 29% of
mutants were deleterious
Bacteriophage Qb 29% Domingo-Calap et al. [7] 29% of single mutations in 42 clones of Qb were considered lethal
Bacteriophage f1 (whole genome) 24% Peris et al. [110] 24% of a total 51 single missense mutants were lethal.
Gene lethality varied 7 to 47%
Bacteriophage WX174 20% Domingo-Calap et al. [7] 20% of single mutations in 45 clones of WX174 were considered lethal
*Table describes single residue mutagenesis studies that were (i) random (i.e. the cohort of mutants was not selected, and did not have amino acid bias) (ii) analysed
proteins or domains greater than 10 aa in length, and (iii) had datasets that included at least 5 mutants.
#Fragility, when not stated clearly in the published work, was deduced using the % of mutants either indicated as ‘lethal’ or that had 2% or less fitness or function
compared to WT, using the available analyses of fitness or function utilized in the study. In most cases, wording of summary/notes mimics the author’s assessment as
closely as possible.
doi:10.1371/journal.ppat.1003461.t004
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mutagenized viral proteins, and full viral genomes. Table 5 lists the
genetic robustness of selected non-viral proteins (it is not inclusive
of all random mutagenesis studies but we were unable to find any
more fragile than those listed). Viruses (particularly ss(+) RNA
viruses) not only have much higher mutation rates than cellular
organisms, but also have comparatively low tolerance to mutation
(Table 4,5) [61,62]. Even when compared to viral genomes or
proteins (e.g. enzymes, Table 5) that exhibit low robustness, HIV-1
CA is more genetically fragile than any other protein or virus for
which this property has been measured.
The extreme mutational fragility of the HIV-1 CA may be
related to the requirement that it maintain a structure that enables
several different sets of interactions. Within the mature hexameric
CA lattice, each CA monomer must interact, via distinct
interfaces, with at least three other CA monomers, and adopt a
rather tightly constrained position with respect to its internal
structure as well as other CA monomers within a hexamer [26].
However, some CA monomers, that have precisely the same
amino acid sequence, must be capable of adopting slightly
different structures and positions relative to other CA monomers
in order to form the pentameric declinations that enable closure of
the CA lattice [16,24]. Furthermore, a different set of CA:CA
interactions are likely required during the formation of immature
virions [15]. In addition to these constraints, the strength of the
various CA:CA interactions in each of the different configurations
probably needs to be finely tuned so that transitions from immature
to mature virions during assembly, and appropriately timed
disassembly, of the capsid can be accomplished in newly infected
cells. Indeed, previous findings have suggested that appropriate
capsid stability is required for HIV-1 infectiousness [63]. Addition-
ally, CA interacts with a variety of host proteins, including
cyclophilin A [23], ABCE1 [22] and possibly with nuclear pore
complex proteins [37] and CPSF6 [34–36]. In summary, the
number of CA interactions and functions, the requirement for CA
to adopt several different structures, and transition between them in
an ordered manner at multiple, critical stages of replication, likely
places tight constraints on sequence and reduces the number of
possible mutations that lack a major fitness cost.
Although lethal CA mutations could in principle affect any one
of multiple steps in the HIV-1 life cycle, we found that most
constitutively non-viable mutants exhibited attenuated particle
formation. Moreover, all of the conditionally non-viable ts mutants
exhibited attenuated particle formation at the non-permissive
temperature. Interestingly, these deficits, at least for the condi-
tionally non-viable mutants, could be rescued by inactivation of
the viral protease. These results indicate that the critical role of CA
in mediating efficient and accurate particle assembly, especially
during Gag proteolysis, is the principal cause of its genetic fragility.
How particle formation, budding and maturation are correctly
orchestrated is not yet fully understood. Over a relatively short
period of time (5–6 minutes) [64], thousands of Gag and Gag-Pol
molecules coalesce and must be cleaved and rearranged through
regimented and dynamically linked processes. Previous work has
demonstrated that incorrect, premature activation of the HIV-1
protease can prevent particle formation [65]. Moreover, other
perturbations of Gag (e.g. partial nucleocapsid deletion) can
attenuate particle formation in a manner that is rescued by
inactivation/inhibition of the viral protease [66,67]. One idea that
could explain these findings is that delayed particle formation may
result in more extensive proteolytic cleavage of Gag early in the
assembly process, thereby attenuating particle formation [66,67].
The finding that many of the constitutively non-viable and all of
the conditionally non-viable CA mutants showed evidence of
perturbed Gag processing with additional ,40 kDa protein
species is consistent with the idea that CA mutations could
similarly delay particle formation, resulting in mistiming of Gag
proteolysis relative to budding and, therefore, protease dependent
attenuation of particle formation. Within this framework, it is
easier to understand how even subtle perturbation of Gag
structure or multimerization caused by single amino acid
substitutions could disrupt the fragile process of HIV-1 assembly,
and thus how critical a role CA plays in orchestrating virion
morphogenesis.
The high frequency with which mutations in the N-terminal
domain of CA result in diminished particle production is
intuitively at odds with earlier findings that the N-terminal
Table 5. Robustness/fragility measurements in non-viral proteins*.
Other Proteins
Protein/Domain Fragility# Author Summary/Notes
E. coli lac repressor ,41% Markiewicz et al. [111] From 4000 single mutants, authors conclude 192 of 328
aa should be tolerant to substitution
3-methyladenine DNA glycosylase (AAG) 34% Guo et al. [112] The calculated probability of a single random amino
acid change inactivating AAG is 34%
Campylobacter jejuni oligosaccaryltransferase PglB 33% Ihssen et al. [113] 16 of the 24 single mutants maintain strong PglB
expression by ELISA
Human interleukin-3 29% Olins et al. [114] From analysis of 770 mutants, 71% of residues were
considered tolerant, as they had $5% of WT bioactivity
Bacillus stearothermophilus a-amylase 20% Holm et al. [57] 12 out of 61 single random mutants had zero enzyme activity
TEM-1 beta-lactamase 16% Huang et al. [115] Authors conclude that 43 of the 263 residues
cannot tolerate substitutions
T15 antibody heavy chain CDR2 7% Chen et al. [116] Just 1 out of 15 single CDR2 mutants lost binding function
Barnase, a bacterial ribonuclease 5% Axe et al. [117] 5% (of over 600 mutants) were found to render
barnase wholly inactive
Human interleukin-1a 2% Kawashima et al. [118] Only 1 out of 56 single mutants appeared to have
significantly impaired activity
*Conditions for inclusion in the table were the same as those listed for Table 4.
doi:10.1371/journal.ppat.1003461.t005
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domain of CA is dispensable for particle formation [68]. It has
already been hypothesized that a misfolded N-terminus (caused by
small changes in CA) could be more disruptive to assembly
processes than deletion [68]. Even without overt misfolding, the
presence of a CA NTD that does not pack correctly or efficiently
into a hexagonal lattice is likely to be more disruptive than NTD
removal to other interactions that are essential for particle
formation (e.g. CA CTD-CTD interactions).
Previous large-scale mutagenesis studies of the retroviral CA
proteins have employed insertional mutagenesis of MLV CA
(using 12 amino acid peptide sequences) [69,70] and alanine
substitution of surface exposed residues in HIV-1 CA [56]. The
fact that 12 amino acid insertions into MLV CA were uniformly
lethal is consistent with the notion that retroviral CA proteins in
general are sensitive to mutation, but insertions are obviously more
likely to perturb CA structure than single amino acid substitutions.
Indeed, a study of MLV CA mutants revealed that only 6 of 15
single amino acid substitutions (40%) in the central portion of CA
were lethal [71]. Interestingly this study found that the most
frequent phenotype associated with single amino acid substitutions
in MLV CA was the generation of non-infectious particles rather
than impaired particle formation, perhaps suggesting a difference
in the properties of MLV and HIV-1 CA proteins. Previously, the
most extensive mutagenesis study of HIV-1 CA [56] generated 48
alanine-scanning mutants that targeted surface exposed residues,
of which 44% were non-viable. This study also found that single
CA mutations in both the CTD and NTD can cause attenuated or
aberrant particle formation, as well as the generation of
morphologically normal virions that are non-infectious [56]. The
difference in the fraction of mutations that were lethal in [56]
versus our study is consistent with our finding that viable CA
mutants tended to be confined to surface-exposed residues while
mutation of the inner core of the CA structure was rarely
compatible with viability. Most notably, we found that sequences
encoding CA helices, particularly those in the NTD, were
especially genetically fragile. These sequences form the funda-
mental structure of the CA hexamer, and in some cases (e.g.
helices 1, 2 and 3), participate in CA:CA interactions within CA
hexamers [26]. Mutations in CTD helices, and in the interhelical
loops (e.g. the CypA binding loop) were less likely to cause lethal
defects. This comparative tolerance of mutations in some portions
of CA appears to correlate, at least partially, with conformational
variation in crystal structures of CA hexamers [26]. In summary,
CA NTD helices appear to be highly structurally constrained and
particularly sensitive to mutations that might perturb the shape or
stability of the CA NTD monomer or the CA hexamer.
By correlating our fitness measurements with an analysis of the
frequency with which mutations occur in natural populations, we
hoped to make observations that neither approach alone could
yield, and make predictions about the outcomes of hypothetical
mutations. For example, all of the mutations that were present in
our library and occurred at a frequency of greater than 3% in
natural populations (n = 9) were quite fit in vitro (.40% of WT
fitness). Conversely, all mutants that exhibited a fitness of,20% of
WT (n = 106) occurred at a frequency of ,1% in natural
populations. This finding indicates that there is some correlation
between fitness and occurrence in natural populations, and
suggests that below an ,40% fitness threshold, mutations rarely
confer a selective advantage within a human host. However, the
correlation between mutant fitness and natural occurrence was
clearly imperfect, indicating the impact of selective pressures other
than fitness on naturally occurring sequences. Specifically, there
was a lack of concordance in fitness and Shannon entropy profiles
in some portions of the CA sequence, and it was striking that more
than half of the mutations that had little or no impact on fitness,
did not occur in natural populations (‘fit but rare’ mutants). This
finding suggests the absence of a selective pressure driving the
emergence of ‘fit but rare’ mutants, or perhaps the presence of a
selective pressure against their emergence. Importantly, we were
unable to demonstrate any defect in the ability of fit but rare CA
mutants to infect primary cells, including primary T-cells and
macrophages. One possible explanation for our findings is that fit
but rare mutants are purged from natural populations because
they confer sensitivity to adaptive or innate immune responses.
Overall, our findings suggest that only ,5% of all possible amino
acid substitutions in CA result in viruses that can flourish in vivo.
An obvious candidate for selective pressure that induces
sequence variation in regions of high genetic fragility, and could
potentially suppress ‘fit but rare’ mutants is that imposed by CTLs.
Indeed, a number of examples of CTL escape mutations in
protective epitopes are characterized by (i) their predictability (i.e.
recurrence of the same mutation in different infected individuals)
[72], (ii) sometimes by their impact on viral fitness [45,73], and (iii)
co-occurrence with compensating mutations, suggesting an impact
of epistatic interactions that alleviate compromised fitness induced
by primary escape mutations [43,44]. All of these findings are
consistent with, and indeed explained by, the finding that CA is
highly genetically fragile, and suggest that the number of possible
mutations that enable escape from CTL responses, with retention
of fitness, is small. However, in considering these arguments, it is
important to recognize that even though our sample of CA
mutants should be representative of random variation, it is only a
sample of the possible mutations that can arise in CA in natural
populations. Analyses in cell culture suggest that a single cycle of
HIV-1 replication (incorporating transcription and reverse tran-
scription steps) generates 1.4 to 3.461025 mutations per
nucleotide [74,75]. For the 231 aa CA protein, this would result
in approximately 0.0097–0.023 errors per replication cycle, or an
amino acid substitution about once or twice per one hundred
replication events. Importantly, the volume and rate of HIV-1
replication in vivo [76] means that every amino acid substitution
that is accessible by a single nucleotide substitution is generated in
nearly every infected individual, many times, every day. Thus,
selective pressures imposed in vivo can act on an enormous pool of
possible variants. The discrepancies between the fitness and
Shannon entropy profiles in Figure 11 suggest that even in CA
domains in which we found few or no fit mutants in our sample of
135 mutants, there do exist rare variants that can thrive in vivo,
even if sometimes they exhibit compromised fitness or require the
co-occurrence of compensating mutations.
Previous work has indicated that the CTL responses to Gag,
rather than other HIV-1 proteins, correlate best with reduced viral
burden during HIV-1 infection [49]. Notably, so-called ‘protec-
tive’ CTL epitopes [44] tended to occur in regions of CA that were
even more intolerant of mutation than CA as a whole.
Additionally, Gag is among the most abundant viral proteins
expressed in HIV-1 infected cells. Its abundance, and the
comparative lack of plasticity in CA, likely both contribute to
the relatively favorable clinical outcome in patients that mount
strong immune responses to the Gag protein [49]. Nevertheless, it
appears that the ability of viral populations to explore essentially
all possible amino acid substitutions, partly overcomes the genetic
fragility of CA and enables at least some degree of escape from
immune responses, even those that target the most vulnerable
areas of CA.
Understanding the fitness effects of mutations in CA may
facilitate drug or vaccine design. For example, one recent study
done in the context of a possible vaccination strategy highlighted
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the observation that mutations in the most conserved residues in
CA are not necessarily associated with the highest fitness costs
[77], as might otherwise be assumed. Thus, a better understanding
of the constraints under which CA evolves may prove beneficial.
Additionally, while CA has not yet been exploited as a target for
drugs in the clinic, recent findings have indicated that it is possible
to do so, at least in principle [78–82]. The genetic fragility
exhibited by CA should reduce, but clearly not eliminate, the
opportunities for drug resistance to occur, and it would be
especially desirable to target CA domains that exhibit the greatest
fragility. In spite of this, resistance to one recently identified CA-
targeted inhibitor arises in vitro through mutations in regions of CA
that exhibit high fragility [79]. Again, it appears that the sheer
number of variants that can be ‘tested’ in natural viral populations
can, at least sometimes, overcome the lack of robustness of HIV-1
CA. Nevertheless, the high genetic fragility exhibited by CA
should facilitate attacks on HIV-1 through vaccination or therapy.
Materials and Methods
Plasmids and construction
A mutagenized CA library was generated using the Genemorph
II random mutagenesis kit (Agilent) using the following oligos 59-
GTA AGA AAA AGG CAC AGC AAG CGG CCG CTG -39
and 59- CTT GGC TCA TTG CTT CAG CCA AAA CGC
GTG-39. The PCR product was cloned using a TOPO TA
Cloning Kit and plasmid DNA was extracted from approximately
,16104 pooled, insert-positive colonies. After sequencing the
amplicon from 20 clones to obtain a preliminary estimate of the
mutagenesis frequency, this pooled plasmid DNA was digested
using NotI and MluI and the CA-library insert subcloned into the
pNHG (JQ585717) derivative pNHGCapNM (JQ686832,
Figure 1A). The NotI and MluI digested proviral plasmid was
prepared in advance and generated .200-fold fewer colonies
when ligated without insert than when ligated with insert.
Furthermore, representative restriction digests indicated that
aberrant restriction patterns, perhaps due to recombination,
occurred at a frequency of only 1–2% of clones. Proviral plasmid
DNA was extracted from individual cultures derived from 1056
colonies and subjected to sequencing and further analysis. Proviral
plasmid DNA from the single mutants listed in tables 1 and 2 was
freshly isolated, re-sequenced and analyzed by NotI and MluI
restriction digest.
The pNL4-3 Pr- plasmid is derived from pNHGCapNM and
pNL4-3 (NIH AIDS Research and Reference Reagent Program,
Catalog No. 114), and has NotI and MluI sites flanking CA as well
as a point mutation in the protease active site, as has been
previously described [83]. CA sequences harboring the tempera-
ture sensitive mutations were transferred from the pNHGcapNM
vector to pNL4-3 Pr- by digestion with NotI and MluI.
Cell lines and transfection
The adherent human cell lines, 293T and TZM-bl, were
maintained in DMEM supplemented with 10% fetal calf serum
(FCS) and gentamicin. Suspension MT-4 cells were maintained in
RPMI with 10% FCS and gentamicin.
For transfection experiments, 293T cells were plated at 2.56104
cells/well in 96 well plates or 1.56105 cells/well in 24 well plates.
To measure the effect of CA mutations, and their temperature
sensitivity, transfections were done the following day using
polyethylenimine (Polysciences), and either 100 ng of the WT or
mutant NHGCapNM plasmids described above (for 96 well plate
experiments) or 500 ng (for 24 well plate experiments), or 500 ng
of the pNL4-3 Pr- mutants (all in 24 well plate experiments). Plates
for all transfection experiments were placed at 35, 37 or 39.5uC, as
indicated, immediately upon addition of transfection mixture.
Primary cells
PBMCs, CD4+ T cells, and macrophages were isolated from
buffy coats (from anonymous healthy blood donors and were
purchased from the New York Blood Center) using a Ficoll
gradient. Primary CD4+ T cells were extracted using a RosetteSep
Human CD4+ T-cell enrichment cocktail. Macrophages were
isolated by adhesion to plastic and treatment with 100 ng/ml of
granulocyte/macrophage-colony stimulating factor (GM-CSF) for
96 hours prior to infection. All primary cells were maintained in
RPMI supplemented with 10% FCS, penicillin/streptomycin, and
L-glutamine. Activation of PBMCs and CD4+ T cells was
achieved by addition of phytohemagglutinin (PHA) at 5 mg/ml
for 72 hours prior to infection, with addition of 25 U/ml of
interleukin-2 at the time of infection.
Viral replication and infectivity assays
293T cells were transfected with the proviral plasmids and given
fresh medium 16 hrs later. At ,40 h post-transfection, cell
supernatants were collected and filtered (0.22 mm). Single-cycle
infectivity was measured using MT-4 cells that were seeded in 96
well plates at 36104/well and inoculated with a volume of filtered
supernatant that was equivalent to an MOI of,1 for the WT viral
clone. Dextran sulfate at 100 mM was added 16 hrs later to limit
replication to a single cycle, and cells were fixed in 4% PFA 48 hrs
after infection. Alternatively, harvested supernatants were subject-
ed to a low-speed spin and a freeze-thaw cycle before addition to
MT-4 or TZM-bl cells in 96 well plates, in the presence or absence
of aphidicolin (2 mg/ml) or at 35, 37, or 39.5uC, as indicated in
figure legends. For spreading replication assays, MT-4 cells were
inoculated with a volume of filtered supernatant that was
equivalent to an MOI of ,0.01 for the WT viral clone and fixed
in 4% PFA at 72–80 hrs post-infection. FACS analysis for all
infectivity and replication assays was carried out using a Guava
EasyCyte instrument.
The following mutations, some of which were part of either
double or triple mutants, occurred in mutants that exhibited
temperature sensitivity in spreading replication assay (Figure S1):
S4C, L189M, I91F; Q6P, A78V; I15M, A78T; S16T, T48A;
S33C, A92V; I91N, D163E; I91V, I124T; M96T; R100S,
Q112L; R132G; R167Q; M214L; K227I. CA mutants encoding
each individual substitution were generated, as necessary, prior to
selection of the 11 ts mutants for analysis in Figures 4 and 5.
Infections of primary cells required different conditions. For
single-cycle infections of PBMCs and CD4+ T cells, 0.1–16106
cells were inoculated using virus generated from 293T cells, as
described above, for the 11 rarely occurring mutants described in
Figure 9C, the WT virus, and 4 randomly selected frequently
occurring mutants from Figure 9B (H87Q, I91V, E98D, T200S) at
an MOI of ,5, and were fixed in 4% PFA 36 hours later. For
infection of macrophages, VSV-pseudotyped virus was generated
in 293T cells for the same 16 mutants plus WT virus.
Macrophages were infected at an MOI of ,4 and fixed
approximately 72 hours later. For spreading infection assays in
PBMC, 16106 cells were infected at an MOI of 0.1, and cells fixed
at the time points indicated in Figure 10C. All MOIs used for
primary cells were reference values derived from titrations on MT-
4 cells.
Western blotting
Cell lysates and virions (pelleted by centrifugation through 20%
sucrose) were resuspended in SDS sample buffer and separated by
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electrophoresis on NuPage 4–12% Bis-Tris Gels (Novex). Proteins
were subsequently blotted onto nitrocellulose membranes, probed
with a primary anti-HIV p24 capsid antibody (183-H12-5C) or
anti-HIV p17 antibody (VU47 Rabbit anti-p17 [84]), and then
probed with a goat anti-mouse/anti-rabbit IRDyeH 800CW
secondary antibody (LI-COR Biosciences). A LI-COR Odyssey
scanner was used to detect and quantify fluorescent signals. A
minimum of 3 separate Western blots was produced for each
temperature sensitive mutant, including those in the protease
negative background, and representative blots are shown.
Structure analysis
HIV-1 capsid hexamer structural analysis was done using
MacPyMOL, with PDB reference 3GV2 [26]. Solvent accessibility
surface area of residues was determined using UCSF Chimera.
Thin-section electron microscopy
To prepare samples for thin-section electron microscopy, 293T
cells were seeded in 6-well plates at 0.86106 cells per well in
duplicate. Transfections were done the following day with the
addition of polyethylenimine to 2 mg of the WT or mutant
NHGcapNM plasmids (S33C, T48A, M96T, Q112L, R132G,
L189M, G60W, K25I, L52F or N195S) plus 0.5 mg of modified
human tetherin (delGI, T451 that is resistant to antagonism by
HIV-1 Vpu [58]) to enhance visualization of virions at the plasma
membrane. Immediately after addition of transfection mixture,
plates were placed at either 37 or 39.5uC, as indicated. After
48 hrs, supernatant was removed and cells were fixed in a solution
of 2% paraformaldehyde (PFA), 2.5% glutaraldehyde. One set of
cells was then analyzed by FACS to compare transfection
efficiencies (which ranged from 23% for WT to 32% for
L189M). The other set were fixed with 2.5% glutaraldehyde and
1% osmium tetroxide, and stained with 2% aqueous uranyl
acetate. Fixed and stained cells were harvested into PBS and
pelleted through 1% SeaPlaque agarose (Flowgen) at 45uC. The
agar was set at 4uC and the cell pellets were cut into ,2 mm
cubes, which were dehydrated through a graded alcohol series and
infiltrated with TAAB 812 embedding resin. After polymerisation,
thin sections (120 nm) were cut and examined in a JEOL 1200 EX
II electron microscope. Numbers of virus particles associated with
150 randomly selected cells were counted for each sample.
Cryo-electron microscopy
To isolate virions for cryo-electron microscopy, 10 cm plates of
approximately 46106 293T cells were transfected with 7 mg of the
indicated plasmids (NHGcapNM, R18G, K30N, G60W or
M215V) using polyethylenimine. After 48 hours, supernatant
was collected and filtered and virions were pelleted by centrifu-
gation at 14000 rpm through 20% sucrose. Virions were fixed in
10 ml of 2% PFA, 2.5% glutaraldehyde solution.
Fixed aliquots of 3 ul of each sample were loaded onto freshly
glow-discharged c-flat holey carbon grids (CF-22-4C, Protochips,
Inc.) held at 4uC and 100% humidity in a Vitrobot vitrification
robot (FEI). Grids were blotted for 4 s prior to being frozen by
plunging into a bath of liquid nitrogen-cooled liquid ethane.
Vitrified specimens were imaged at low temperature in a JEOL
2200 FS cryo-microscope equipped with Gatan 626 cryo-stages.
Low dose (10 e/A˚2), energy-filtered images (slit width, 20 eV)
were recorded on a Gatan ultrascan 16-megapixel charge-
coupled-device camera at a magnification of 50,0006.
Analysis of natural CA variants
A set of 1,000 HIV-1 subtype B sequences isolates was obtained
from the Los Alamos HIV sequence database (www.hiv.lanl.gov/).
All sequences were sampled from distinct infections between from
1980 and 2009. To minimize risks of sampling biases, multiple
sequences from known transmission clusters were excluded.
Sequences with frameshift mutations or stop codons that were
likely to represent nonfunctional viruses or poor quality sequenc-
ing were excluded. Sequences were aligned using MUSCLE [85],
and PERL scripts were used to examine genetic variation in the
resulting sequence alignment. An information-theoretic measure
of diversity (Shannon’s entropy) [86] was applied to quantify the
amount of amino acid variation at each position in capsid.
Supporting Information
Figure S1 Temperature sensitive mutants in entire CA mutant
library. The Y-axis indicates the percentage of infected (GFP+)
MT-4 cells from mutant viruses following a spreading replication
assay done at 35uC, while the x-axis shows the percentage of
infected cells following a spreading replication assay done at
39.5uC. Mutants that generated less than 0.1% infected cells are
not shown.
(TIF)
Acknowledgments
We thank Theodora Hatziioannou for review of the manuscript and
members of the Bieniasz Laboratory for reagents and advice. We also
thank Ian Salt for thoughtful advice and for the use of a LiCOR infrared
imaging system made possible by support from Diabetes UK to Ian Salt
and colleagues at the University of Glasgow. The following reagents were
obtained through the NIH AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH: hybridoma 183-H12-5C
(#1513) from Bruce Chesebro, antiserum to p17 (# 4811) from Paul
Spearman and pNL4-3 (# 114) from Malcolm Martin.
Author Contributions
Conceived and designed the experiments: SJR SJW PDB. Performed the
experiments: SJR SJW MA SEB DB FJR. Analyzed the data: SJR SJW
NJL RJG PDB. Contributed reagents/materials/analysis tools: NJL RJG.
Wrote the paper: SJR SJW PDB.
References
1. de Visser JA, Hermisson J, Wagner GP, Ancel Meyers L, Bagheri-Chaichian
H, et al. (2003) Perspective: Evolution and detection of genetic robustness.
Evolution 57: 1959–1972.
2. Wagner A (2005) Robustness, evolvability, and neutrality. FEBS Lett 579:
1772–1778.
3. Elena SF (2012) RNA virus genetic robustness: possible causes and some
consequences. Curr Opin Virol 2: 525–530.
4. Montville R, Froissart R, Remold SK, Tenaillon O, Turner PE (2005)
Evolution of mutational robustness in an RNA virus. PLoS Biol 3: e381.
5. Codoner FM, Daros JA, Sole RV, Elena SF (2006) The fittest versus the flattest:
experimental confirmation of the quasispecies effect with subviral pathogens.
PLoS Pathog 2: e136.
6. Sanjuan R, Cuevas JM, Furio V, Holmes EC, Moya A (2007) Selection for
robustness in mutagenized RNA viruses. PLoS Genet 3: e93.
7. Domingo-Calap P, Cuevas JM, Sanjuan R (2009) The fitness effects of random
mutations in single-stranded DNA and RNA bacteriophages. PLoS Genet 5: e1000742.
8. Sanjuan R, Moya A, Elena SF (2004) The distribution of fitness effects caused
by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci U S A
101: 8396–8401.
9. Carrasco P, de la Iglesia F, Elena SF (2007) Distribution of fitness and virulence
effects caused by single-nucleotide substitutions in Tobacco Etch virus. J Virol
81: 12979–12984.
10. Bieniasz PD (2009) The cell biology of HIV-1 virion genesis. Cell Host Microbe
5: 550–558.
Genetic Fragility in the HIV-1 Capsid
PLOS Pathogens | www.plospathogens.org 23 June 2013 | Volume 9 | Issue 6 | e1003461
11. Freed EO (1998) HIV-1 gag proteins: diverse functions in the virus life cycle.
Virology 251: 1–15.
12. Ganser-Pornillos BK, Yeager M, Sundquist WI (2008) The structural biology of
HIV assembly. Curr Opin Struct Biol 18: 203–217.
13. Sundquist WI, Krausslich HG (2012) HIV-1 Assembly, Budding, and
Maturation. Cold Spring Harb Perspect Med 2: a006924.
14. Briggs JA, Krausslich HG (2011) The molecular architecture of HIV. J Mol
Biol 410: 491–500.
15. Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, et al. (2009) Structure
and assembly of immature HIV. Proc Natl Acad Sci U S A 106: 11090–11095.
16. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI (1999) Assembly and
analysis of conical models for the HIV-1 core. Science 283: 80–83.
17. Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI
(2004) Assembly properties of the human immunodeficiency virus type 1 CA
protein. J Virol 78: 2545–2552.
18. Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, et al.
(1997) Structure of the carboxyl-terminal dimerization domain of the HIV-1
capsid protein. Science 278: 849–853.
19. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, et al. (1996)
Crystal structure of human cyclophilin A bound to the amino-terminal domain
of HIV-1 capsid. Cell 87: 1285–1294.
20. Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, et al. (1996) Structure of
the amino-terminal core domain of the HIV-1 capsid protein. Science 273:
231–235.
21. Chang YF, Wang SM, Huang KJ, Wang CT (2007) Mutations in capsid major
homology region affect assembly and membrane affinity of HIV-1 Gag. J Mol
Biol 370: 585–597.
22. Zimmerman C, Klein KC, Kiser PK, Singh AR, Firestein BL, et al. (2002)
Identification of a host protein essential for assembly of immature HIV-1
capsids. Nature 415: 88–92.
23. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP (1993) Human
immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell
73: 1067–1078.
24. Pornillos O, Ganser-Pornillos BK, Yeager M (2011) Atomic-level modelling of
the HIV capsid. Nature 469: 424–427.
25. Li S, Hill CP, Sundquist WI, Finch JT (2000) Image reconstructions of helical
assemblies of the HIV-1 CA protein. Nature 407: 409–413.
26. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, et al. (2009)
X-ray structures of the hexameric building block of the HIV capsid. Cell 137:
1282–1292.
27. Lanman J, Lam TT, Barnes S, Sakalian M, Emmett MR, et al. (2003)
Identification of novel interactions in HIV-1 capsid protein assembly by high-
resolution mass spectrometry. J Mol Biol 325: 759–772.
28. Lanman J, Lam TT, Emmett MR, Marshall AG, Sakalian M, et al. (2004) Key
interactions in HIV-1 maturation identified by hydrogen-deuterium exchange.
Nat Struct Mol Biol 11: 676–677.
29. Mateu MG (2009) The capsid protein of human immunodeficiency virus:
intersubunit interactions during virus assembly. FEBS J 276: 6098–6109.
30. Yamashita M, Perez O, Hope TJ, Emerman M (2007) Evidence for direct
involvement of the capsid protein in HIV infection of nondividing cells. PLoS
Pathog 3: 1502–1510.
31. Yamashita M, Emerman M (2004) Capsid is a dominant determinant of
retrovirus infectivity in nondividing cells. J Virol 78: 5670–5678.
32. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, et al. (2010) The
requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection
maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol
84: 397–406.
33. Matreyek KA, Engelman A (2011) The requirement for nucleoporin NUP153
during human immunodeficiency virus type 1 infection is determined by the
viral capsid. J Virol 85: 7818–7827.
34. Lee K, Mulky A, Yuen W, Martin TD, Meyerson NR, et al. (2012) HIV-1
capsid-targeting domain of cleavage and polyadenylation specificity factor 6.
J Virol 86: 3851–3860.
35. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, et al. (2010) Flexible use of
nuclear import pathways by HIV-1. Cell Host Microbe 7: 221–233.
36. Price AJ, Fletcher AJ, Schaller T, Elliott T, Lee K, et al. (2012) CPSF6 defines a
conserved capsid interface that modulates HIV-1 replication. PLoS Pathog 8:
e1002896.
37. Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, et al. (2011) HIV-1
capsid-cyclophilin interactions determine nuclear import pathway, integration
targeting and replication efficiency. PLoS Pathog 7: e1002439.
38. Hatziioannou T, Perez-Caballero D, Cowan S, Bieniasz PD (2005) Cyclophilin
interactions with incoming human immunodeficiency virus type 1 capsids with
opposing effects on infectivity in human cells. J Virol 79: 176–183.
39. Sokolskaja E, Sayah DM, Luban J (2004) Target cell cyclophilin A modulates
human immunodeficiency virus type 1 infectivity. J Virol 78: 12800–12808.
40. Qi M, Yang R, Aiken C (2008) Cyclophilin A-dependent restriction of human
immunodeficiency virus type 1 capsid mutants for infection of nondividing
cells. J Virol 82: 12001–12008.
41. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The
cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old
World monkeys. Nature 427: 848–853.
42. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, et al. (2010) A cryptic
sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature
467: 214–217.
43. Crawford H, Matthews PC, Schaefer M, Carlson JM, Leslie A, et al. (2011)
The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+
T-cell escape mutations and covarying HLA-independent polymorphisms.
J Virol 85: 1384–1390.
44. Dahirel V, Shekhar K, Pereyra F, Miura T, Artyomov M, et al. (2011)
Coordinate linkage of HIV evolution reveals regions of immunological
vulnerability. Proc Natl Acad Sci U S A 108: 11530–11535.
45. Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, et al. (2010) Early
selection in Gag by protective HLA alleles contributes to reduced HIV-1
replication capacity that may be largely compensated for in chronic infection.
J Virol 84: 11937–11949.
46. Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, et al. (2012)
Correlates of Protective Cellular Immunity Revealed by Analysis of Population-
Level Immune Escape Pathways in HIV-1. J Virol 86: 13202–13216.
47. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB (1994) Virus-
specific CD8+ cytotoxic T-lymphocyte activity associated with control of
viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:
6103–6110.
48. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al. (2010) The major
genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Science 330: 1551–1557.
49. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, et al.
(2007) CD8+ T-cell responses to different HIV proteins have discordant
associations with viral load. Nat Med 13: 46–53.
50. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, et al. (2001) Clustered
mutations in HIV-1 gag are consistently required for escape from HLA-B27-
restricted cytotoxic T lymphocyte responses. J Exp Med 193: 375–386.
51. Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, et al. (2009) Variable
fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL)
response. PLoS Pathog 5: e1000365.
52. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. (2004) HIV
evolution: CTL escape mutation and reversion after transmission. Nat Med 10:
282–289.
53. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, et al. (1995) Linker
insertion mutations in the human immunodeficiency virus type 1 gag gene:
effects on virion particle assembly, release, and infectivity. J Virol 69: 642–650.
54. Srinivasakumar N, Hammarskjold ML, Rekosh D (1995) Characterization of
deletion mutations in the capsid region of human immunodeficiency virus type
1 that affect particle formation and Gag-Pol precursor incorporation. J Virol
69: 6106–6114.
55. Fitzon T, Leschonsky B, Bieler K, Paulus C, Schroder J, et al. (2000) Proline
residues in the HIV-1 NH2-terminal capsid domain: structure determinants for
proper core assembly and subsequent steps of early replication. Virology 268:
294–307.
56. von Schwedler UK, Stray KM, Garrus JE, Sundquist WI (2003) Functional
surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 77:
5439–5450.
57. Holm L, Koivula AK, Lehtovaara PM, Hemminki A, Knowles JK (1990)
Random mutagenesis used to probe the structure and function of Bacillus
stearothermophilus alpha-amylase. Protein Eng 3: 181–191.
58. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, et al. (2009)
Species-specific activity of HIV-1 Vpu and positive selection of tetherin
transmembrane domain variants. PLoS Pathog 5: e1000300.
59. Hatziioannou T, Cowan S, Von Schwedler UK, Sundquist WI, Bieniasz PD
(2004) Species-specific tropism determinants in the human immunodeficiency
virus type 1 capsid. J Virol 78: 6005–6012.
60. Ambrose Z, Lee K, Ndjomou J, Xu H, Oztop I, et al. (2012) Human
immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A
dependence and impairs macrophage infection. J Virol 86: 4708–4714.
61. Sanjuan R, Nebot MR, Chirico N, Mansky LM, Belshaw R (2010) Viral
mutation rates. J Virol 84: 9733–9748.
62. Sanjuan R (2010) Mutational fitness effects in RNA and single-stranded DNA
viruses: common patterns revealed by site-directed mutagenesis studies. Philos
Trans R Soc Lond B Biol Sci 365: 1975–1982.
63. Forshey BM, von Schwedler U, Sundquist WI, Aiken C (2002) Formation of a
human immunodeficiency virus type 1 core of optimal stability is crucial for
viral replication. J Virol 76: 5667–5677.
64. Jouvenet N, Bieniasz PD, Simon SM (2008) Imaging the biogenesis of
individual HIV-1 virions in live cells. Nature 454: 236–240.
65. Krausslich HG (1991) Human immunodeficiency virus proteinase dimer as
component of the viral polyprotein prevents particle assembly and viral
infectivity. Proc Natl Acad Sci U S A 88: 3213–3217.
66. Ott DE, Coren LV, Chertova EN, Gagliardi TD, Nagashima K, et al. (2003)
Elimination of protease activity restores efficient virion production to a human
immunodeficiency virus type 1 nucleocapsid deletion mutant. J Virol 77: 5547–
5556.
67. Ott DE, Coren LV, Shatzer T (2009) The nucleocapsid region of human
immunodeficiency virus type 1 Gag assists in the coordination of assembly and
Gag processing: role for RNA-Gag binding in the early stages of assembly.
J Virol 83: 7718–7727.
Genetic Fragility in the HIV-1 Capsid
PLOS Pathogens | www.plospathogens.org 24 June 2013 | Volume 9 | Issue 6 | e1003461
68. Borsetti A, Ohagen A, Gottlinger HG (1998) The C-terminal half of the human
immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle
assembly. J Virol 72: 9313–9317.
69. Auerbach MR, Shu C, Kaplan A, Singh IR (2003) Functional characterization
of a portion of the Moloney murine leukemia virus gag gene by genetic
footprinting. Proc Natl Acad Sci U S A 100: 11678–11683.
70. Auerbach MR, Brown KR, Singh IR (2007) Mutational analysis of the N-
terminal domain of Moloney murine leukemia virus capsid protein. J Virol 81:
12337–12347.
71. Alin K, Goff SP (1996) Amino acid substitutions in the CA protein of Moloney
murine leukemia virus that block early events in infection. Virology 222: 339–
351.
72. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, et al. (2005) Selective
escape from CD8+ T-cell responses represents a major driving force of human
immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals
constraints on HIV-1 evolution. J Virol 79: 13239–13249.
73. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, et al. (2006)
Fitness cost of escape mutations in p24 Gag in association with control of
human immunodeficiency virus type 1. J Virol 80: 3617–3623.
74. Mansky LM, Temin HM (1995) Lower in vivo mutation rate of human
immunodeficiency virus type 1 than that predicted from the fidelity of purified
reverse transcriptase. J Virol 69: 5087–5094.
75. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH (2010) Nature,
position, and frequency of mutations made in a single cycle of HIV-1
replication. J Virol 84: 9864–9878.
76. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1
dynamics in vivo: virion clearance rate, infected cell life-span, and viral
generation time. Science 271: 1582–1586.
77. Rolland M, Manocheewa S, Swain JV, Lanxon-Cookson EC, Kim M, et al.
(2013) HIV-1 Conserved-Element Vaccines: Relationship between Sequence
Conservation and Replicative Capacity. J Virol 87: 5461–5467.
78. Tang C, Loeliger E, Kinde I, Kyere S, Mayo K, et al. (2003) Antiviral
inhibition of the HIV-1 capsid protein. J Mol Biol 327: 1013–1020.
79. Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, et al. (2010) HIV
capsid is a tractable target for small molecule therapeutic intervention. PLoS
Pathog 6: e1001220.
80. Sticht J, Humbert M, Findlow S, Bodem J, Muller B, et al. (2005) A peptide
inhibitor of HIV-1 assembly in vitro. Nat Struct Mol Biol 12: 671–677.
81. Zhang H, Zhao Q, Bhattacharya S, Waheed AA, Tong X, et al. (2008) A cell-
penetrating helical peptide as a potential HIV-1 inhibitor. J Mol Biol 378: 565–
580.
82. Lemke CT, Titolo S, von Schwedler U, Goudreau N, Mercier JF, et al. (2012)
Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the
same site within the N-terminal domain of the viral CA protein. J Virol 86:
6643–6655.
83. Zhang F, Zang T, Wilson SJ, Johnson MC, Bieniasz PD (2011) Clathrin
facilitates the morphogenesis of retrovirus particles. PLoS Pathog 7: e1002119.
84. Varthakavi V, Browning PJ, Spearman P (1999) Human immunodeficiency
virus replication in a primary effusion lymphoma cell line stimulates lytic-phase
replication of Kaposi’s sarcoma-associated herpesvirus. J Virol 73: 10329–
10338.
85. Edgar RC (2004) MUSCLE: a multiple sequence alignment method with
reduced time and space complexity. BMC Bioinformatics 5: 113.
86. Shenkin PS, Erman B, Mastrandrea LD (1991) Information-theoretical entropy
as a measure of sequence variability. Proteins 11: 297–313.
87. Shao W, Everitt L, Manchester M, Loeb DD, Hutchison CA, 3rd, et al. (1997)
Sequence requirements of the HIV-1 protease flap region determined by
saturation mutagenesis and kinetic analysis of flap mutants. Proc Natl Acad
Sci U S A 94: 2243–2248.
88. Parera M, Fernandez G, Clotet B, Martinez MA (2007) HIV-1 protease
catalytic efficiency effects caused by random single amino acid substitutions.
Mol Biol Evol 24: 382–387.
89. Loeb DD, Swanstrom R, Everitt L, Manchester M, Stamper SE, et al. (1989)
Complete mutagenesis of the HIV-1 protease. Nature 340: 397–400.
90. Chao SF, Chan VL, Juranka P, Kaplan AH, Swanstrom R, et al. (1995)
Mutational sensitivity patterns define critical residues in the palm subdomain of
the reverse transcriptase of human immunodeficiency virus type 1. Nucleic
Acids Res 23: 803–810.
91. van den Ent FM, Vos A, Plasterk RH (1998) Mutational scan of the human
immunodeficiency virus type 2 integrase protein. J Virol 72: 3916–3924.
92. Smith RA, Anderson DJ, Preston BD (2006) Hypersusceptibility to substrate
analogs conferred by mutations in human immunodeficiency virus type 1
reverse transcriptase. J Virol 80: 7169–7178.
93. van Opijnen T, Boerlijst MC, Berkhout B (2006) Effects of random mutations
in the human immunodeficiency virus type 1 transcriptional promoter on viral
fitness in different host cell environments. J Virol 80: 6678–6685.
94. Kim B, Hathaway TR, Loeb LA (1996) Human immunodeficiency virus
reverse transcriptase. Functional mutants obtained by random mutagenesis
coupled with genetic selection in Escherichia coli. J Biol Chem 271: 4872–
4878.
95. Yasugi T, Vidal M, Sakai H, Howley PM, Benson JD (1997) Two classes of
human papillomavirus type 16 E1 mutants suggest pleiotropic conformational
constraints affecting E1 multimerization, E2 interaction, and interaction with
cellular proteins. J Virol 71: 5942–5951.
96. Morrison HG, Kirchhoff F, Desrosiers RC (1995) Effects of mutations in
constant regions 3 and 4 of envelope of simian immunodeficiency virus.
Virology 210: 448–455.
97. Nakajima K, Nobusawa E, Tonegawa K, Nakajima S (2003) Restriction of
amino acid change in influenza A virus H3HA: comparison of amino acid
changes observed in nature and in vitro. J Virol 77: 10088–10098.
98. Yano T, Nobusawa E, Nagy A, Nakajima S, Nakajima K (2008) Effects of
single-point amino acid substitutions on the structure and function neuramin-
idase proteins in influenza A virus. Microbiol Immunol 52: 216–223.
99. Pakula AA, Young VB, Sauer RT (1986) Bacteriophage lambda cro mutations:
effects on activity and intracellular degradation. Proc Natl Acad Sci U S A 83:
8829–8833.
100. Rhee SS, Hunter E (1991) Amino acid substitutions within the matrix protein
of type D retroviruses affect assembly, transport and membrane association of a
capsid. EMBO J 10: 535–546.
101. Terwilliger TC, Zabin HB, Horvath MP, Sandberg WS, Schlunk PM (1994) In
vivo characterization of mutants of the bacteriophage f1 gene V protein
isolated by saturation mutagenesis. J Mol Biol 236: 556–571.
102. Masso M, Mathe E, Parvez N, Hijazi K, Vaisman II (2009) Modeling the
functional consequences of single residue replacements in bacteriophage f1
gene V protein. Protein Eng Des Sel 22: 665–671.
103. Suzutani T, Lacey SF, Powell KL, Purifoy DJ, Honess RW (1992) Random
mutagenesis of the thymidine kinase gene of varicella-zoster virus. J Virol 66:
2118–2124.
104. Eifan SA, Elliott RM (2009) Mutational analysis of the Bunyamwera
orthobunyavirus nucleocapsid protein gene. J Virol 83: 11307–11317.
105. Stenger DC, Young BA, French R (2006) Random mutagenesis of wheat streak
mosaic virus HC-Pro: non-infectious interfering mutations in a gene
dispensable for systemic infection of plants. J Gen Virol 87: 2741–2747.
106. Rennell D, Bouvier SE, Hardy LW, Poteete AR (1991) Systematic mutation of
bacteriophage T4 lysozyme. J Mol Biol 222: 67–88.
107. Strambio-de-Castillia C, Hunter E (1992) Mutational analysis of the major
homology region of Mason-Pfizer monkey virus by use of saturation
mutagenesis. J Virol 66: 7021–7032.
108. Moyer CL, Wiethoff CM, Maier O, Smith JG, Nemerow GR (2011)
Functional genetic and biophysical analyses of membrane disruption by
human adenovirus. J Virol 85: 2631–2641.
109. Van Der Velden A, Kaminski A, Jackson RJ, Belsham GJ (1995) Defective
point mutants of the encephalomyocarditis virus internal ribosome entry site
can be complemented in trans. Virology 214: 82–90.
110. Peris JB, Davis P, Cuevas JM, Nebot MR, Sanjuan R (2010) Distribution of
fitness effects caused by single-nucleotide substitutions in bacteriophage f1.
Genetics 185: 603–609.
111. Markiewicz P, Kleina LG, Cruz C, Ehret S, Miller JH (1994) Genetic studies of
the lac repressor. XIV. Analysis of 4000 altered Escherichia coli lac repressors
reveals essential and non-essential residues, as well as ‘‘spacers’’ which do not
require a specific sequence. J Mol Biol 240: 421–433.
112. Guo HH, Choe J, Loeb LA (2004) Protein tolerance to random amino acid
change. Proc Natl Acad Sci U S A 101: 9205–9210.
113. Ihssen J, Kowarik M, Wiesli L, Reiss R, Wacker M, et al. (2012) Structural
insights from random mutagenesis of Campylobacter jejuni oligosaccharyl-
transferase PglB. BMC Biotechnol 12: 67.
114. Olins PO, Bauer SC, Braford-Goldberg S, Sterbenz K, Polazzi JO, et al. (1995)
Saturation mutagenesis of human interleukin-3. J Biol Chem 270: 23754–
23760.
115. Huang W, Petrosino J, Hirsch M, Shenkin PS, Palzkill T (1996) Amino acid
sequence determinants of beta-lactamase structure and activity. J Mol Biol 258:
688–703.
116. Chen C, Roberts VA, Rittenberg MB (1992) Generation and analysis of
random point mutations in an antibody CDR2 sequence: many mutated
antibodies lose their ability to bind antigen. J Exp Med 176: 855–866.
117. Axe DD, Foster NW, Fersht AR (1998) A search for single substitutions that
eliminate enzymatic function in a bacterial ribonuclease. Biochemistry 37:
7157–7166.
118. Kawashima H, Yamagishi J, Yamayoshi M, Ohue M, Fukui T, et al. (1992)
Structure-activity relationships in human interleukin-1 alpha: identification of
key residues for expression of biological activities. Protein Eng 5: 171–176.
Genetic Fragility in the HIV-1 Capsid
PLOS Pathogens | www.plospathogens.org 25 June 2013 | Volume 9 | Issue 6 | e1003461
